Otitis media, unspecified

H8_OTIMEDNAS

Otitis media: Inflammation of the anatomical structures of the middle ear, which is most often caused by an infectious process. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H66.9
  • Hospital discharge: ICD-8 3819
  • Cause of death: ICD-10 H66.9
  • Cause of death: ICD-8 3819

2 out of 7 registries used, show all original rules.

5457

4. Check minimum number of events

None

5457

5. Include endpoints

None

5457

6. Filter based on genotype QC (FinnGen only)

5457

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H66
Name in latin
Otitis media non specificata

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 149321 66988 82178
Only index persons 106058 48151 57907
Unadjusted period prevalence (%)
Whole population 2.12 1.92 2.30
Only index persons 2.01 1.77 2.21
Median age at first event (years)
Whole population 2.63 2.92 2.32
Only index persons 3.24 3.79 2.78

-FinnGen-

Key figures

All Female Male
Number of individuals 5457 3433 2024
Unadjusted period prevalence (%) 1.07 1.17 0.89
Median age at first event (years) 15.78 15.90 15.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4432
Matched controls
41859
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EMB30
NOMESCO Finland
Adenotomy
9.3
323.0
765
919
UDC00
NOMESCO Finland
Ear microscopy
9.1
323.0
814
1012
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
111.5
323.0
873
92
H65.3
ICD-10 Finland
Chronic mucoid otitis media
366.9
323.0
628
19
38199
ICD-8 Finland
Otitis media without mention of mastoiditis, Unspecified
+∞
323.0
414
*
H66.9
ICD-10 Finland
Otitis media, unspecified
323.1
323.0
4035
1278
H66.0
ICD-10 Finland
Acute suppurative otitis media
10.8
323.0
1273
1507
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
241.1
318.3
331
14
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
21.9
275.2
418
198
H65.2
ICD-10 Finland
Chronic serous otitis media
266.5
255.8
265
10
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
63.1
232.0
276
44
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.1
190.7
852
2290
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
183.1
2807
16997
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.5
169.0
1846
9158
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
66.2
154.2
182
27
H71
ICD-10 Finland
Cholesteatoma of middle ear
299.5
147.2
152
5
J01FA10
ATC
azithromycin; systemic
2.2
129.4
3123
21611
J01CA04
ATC
amoxicillin; systemic
3.0
124.9
4028
32032
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
120.8
118
*
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
108.7
120.7
134
12
DCD00
NOMESCO Finland
Myringoplasty
1133.5
117.8
117
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
4.0
117.3
515
1322
H65.0
ICD-10 Finland
Acute serous otitis media
10.9
109.1
218
197
H01
ICPC
Ear pain/earache
2.7
105.2
873
3536
DFF00
NOMESCO Finland
Pure tone audiometry
4.3
103.1
412
964
J35.2
ICD-10 Finland
Hypertrophy of adenoids
4.5
101.9
395
897
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
29.0
98.7
137
46
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
98.2
96
*
4122
FHL
Tympanostomy (tympanic tube)
33.5
97.8
131
38
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
5.9
93.0
279
475
DC1AD
NOMESCO Finland
Temporalbone CT
21.4
87.2
132
60
H60.3
ICD-10 Finland
Other infective otitis externa
8.0
87.1
208
257
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
31.9
82.8
112
34
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
79.7
78
*
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
+∞
77.7
76
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
72.6
71
*
H92.0
ICD-10 Finland
Otalgia
3.4
70.9
381
1139
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.2
70.2
818
3862
J01DA01
ATC
[U] cefalexin; systemic
1.7
68.8
2457
17396
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
83.3
68.4
78
9
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
12.5
67.3
125
97
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
66.5
751
3487
J45.1
ICD-10 Finland
Nonallergic asthma
3.1
63.6
389
1274
J01FA09
ATC
clarithromycin; systemic
1.8
63.3
1379
8276
H60.8
ICD-10 Finland
Other otitis externa
5.2
61.6
201
377
ZXA10
NOMESCO Finland
Bilateral
2.2
61.3
692
3200
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
+∞
59.2
58
*
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
59.2
58
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
58.6
2402
17331
R03AC02
ATC
salbutamol; inhalant
1.7
58.0
2199
15507
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
56.8
1057
5965
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.1
55.1
321
1013
R03BA05
ATC
fluticasone; inhalant
2.0
54.6
859
4550
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
138.7
53.7
58
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.6
53.6
434
1686
J01DA08
ATC
[U] cefaclor; oral
2.0
52.1
826
4374
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
11.5
51.6
99
83
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.8
51.4
179
361
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
50.7
704
3537
H66
ICD-10 Finland
Suppurative and unspecified otitis media
3.8
49.8
225
582
R01AD09
ATC
mometasone; nasal
1.6
49.1
1821
12552
J01DB01
ATC
cefalexin; oral
1.7
48.2
3425
27914
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
48.0
47
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
47.3
485
2126
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
+∞
47.0
46
*
S02CA02
ATC
flumetasone and antiinfectives; otic
3.5
46.2
227
630
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.6
45.4
358
1364
DGW00
NOMESCO Finland
Dilatation of eustachian tube
436.9
45.3
46
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
45.3
722
3814
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
44.9
44
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
44.5
790
4333
H02AB06
ATC
prednisolone; systemic
1.6
43.9
1571
10635
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
9.0
43.3
94
100
H29
ICPC
Ear symptom/complaint other
2.3
43.1
420
1792
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
42.1
1288
8338
4141
FHL
Myringoplasty (also for reasons other than inflammation)
+∞
41.8
41
*
R50.9
ICD-10 Finland
Fever, unspecified
1.9
41.4
652
3415
R03BA02
ATC
budesonide; inhalant
1.9
40.7
701
3794
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.4
39.9
209
609
J01DA06
ATC
[U] cefuroxime; systemic
2.1
39.9
512
2472
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
5.5
39.6
122
215
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
39.3
796
4546
R01AD08
ATC
fluticasone; nasal
1.7
39.2
1056
6576
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
39.1
1528
10493
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
38.8
366
1533
TDA90
NOMESCO Finland
Removal wax from ear
9.0
38.6
84
90
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
37.8
37
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
37.7
1276
8434
ZXE00
NOMESCO Finland
One hour or less
1.6
37.7
1462
9998
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
36.1
310
1236
J04.0
ICD-10 Finland
Acute laryngitis
2.6
35.6
270
1006
R03DC03
ATC
montelukast; oral
1.8
35.3
646
3554
4451
FHL
Guitar cutting
3.5
35.2
170
466
R51.80
ICD-10 Finland
Headache
1.8
34.9
743
4294
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
120.6
34.9
38
*
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
34.7
34
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
34.5
967
6052
H04
ICPC
Ear discharge
4.0
34.1
143
347
M01AE02
ATC
naproxen; oral, rectal
1.5
33.5
2447
19070
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.5
33.3
123
265
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.4
32.6
167
479
R01AD12
ATC
fluticasone furoate; nasal
1.5
32.0
1278
8719
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
31.9
321
1386
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
31.8
729
4298
H02AB04
ATC
methylprednisolone; systemic
2.0
31.3
433
2146
Z97.4
ICD-10 Finland
Presence of external hearing-aid
4.2
31.2
122
278
R03CC02
ATC
salbutamol; systemic
1.7
31.1
738
4394
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
+∞
30.6
30
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
29.9
263
1062
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
4.1
29.7
119
278
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
+∞
29.6
29
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
29.3
269
1110
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
287.3
29.2
30
*
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.3
28.7
282
1204
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
28.6
28
*
EMB10
NOMESCO Finland
Tonsillectomy
2.0
27.6
375
1842
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
27.6
443
2319
DEB30
NOMESCO Finland
Radical mastoidectomy
+∞
27.5
27
*
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
+∞
27.5
27
*
J01MA02
ATC
ciprofloxacin; systemic
1.5
27.5
1079
7283
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
267.4
27.1
28
*
H60
ICD-10 Finland
Otitis externa
2.5
27.0
220
853
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
5.9
26.8
77
126
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
+∞
26.5
26
*
H71
ICPC
Acute otitis media/myringitis
3.7
26.3
118
306
R42
ICD-10 Finland
Dizziness and giddiness
1.7
26.2
638
3811
H92.1
ICD-10 Finland
Otorrhoea
17.7
26.0
41
22
H73.1
ICD-10 Finland
Chronic myringitis
+∞
25.5
25
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
25.4
509
2865
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
25.4
194
726
J35.8
ICD-10 Finland
Other chronic diseases of tonsils and adenoids
4.6
24.9
88
183
J01AA02
ATC
doxycycline; systemic
1.4
24.5
2390
19137
H70.0
ICD-10 Finland
Acute mastoiditis
+∞
24.5
24
*
3810A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media
+∞
24.5
24
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
24.5
923
6151
B34.9
ICD-10 Finland
Viral infection, unspecified
2.5
24.4
201
785
M79.6
ICD-10 Finland
Pain in limb
1.5
24.4
1183
8321
DCD10
NOMESCO Finland
Tympanoplasty
66.4
24.2
28
*
N02AX02
ATC
tramadol; systemic, rectal
1.5
24.1
1127
7865
J01FF01
ATC
clindamycin; systemic
1.5
24.1
832
5431
J35.1
ICD-10 Finland
Hypertrophy of tonsils
2.7
23.7
169
607
J01DC02
ATC
cefuroxime; systemic
2.3
23.6
232
990
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
23.5
784
5067
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
7.5
23.5
56
71
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
22.9
584
3523
XG410
NOMESCO Finland
Flow-volume spirometry
2.6
22.6
169
625
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
22.5
140
462
R03AC03
ATC
terbutaline; inhalant
1.7
22.3
490
2830
N02BE01
ATC
paracetamol; systemic, rectal
1.4
22.2
3109
26253
H13
ICPC
Plugged feeling ear
1.7
21.9
545
3260
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
21.8
2069
16346
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
21.7
262
1227
J01MA12
ATC
levofloxacin; systemic
1.7
21.5
463
2661
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
21.4
621
3871
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
21.3
3093
26162
J45.8
ICD-10 Finland
Mixed asthma
2.9
21.1
131
432
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
8.4
20.8
46
52
DAX08
NOMESCO Finland
Fitting of hearing aid
3.4
20.8
103
291
K02.1
ICD-10 Finland
Caries of dentine
1.4
20.6
2548
20931
R06.2
ICD-10 Finland
Wheezing
2.3
20.5
195
817
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
20.5
1948
15342
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.8
20.4
391
2165
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
20.4
20
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
20.3
2910
24442
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
6.7
20.3
52
74
R06AE07
ATC
cetirizine; oral
1.4
20.2
1744
13512
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
20.2
852
5790
R05
ICPC
Cough
1.5
20.1
922
6369
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
20.1
455
2651
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.3
20.0
187
780
SPAT1260
SPAT
Consultation of another employee
1.5
19.9
676
4375
127
Kela drug reimbursment
Transplant complication
4.4
19.9
73
159
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.4
19.8
180
740
ZXA00
NOMESCO Finland
Right side
1.5
19.6
679
4414
DFF15
NOMESCO Finland
Speech audiometry
3.2
19.6
106
320
SPAT1312
SPAT
General health counselling
1.4
19.5
1661
12816
J46
ICD-10 Finland
Status asthmaticus
3.2
19.5
104
311
H69.0
ICD-10 Finland
Patulous Eustachian tube
15.2
19.4
32
20
DEB00
NOMESCO Finland
Cortical mastoidectomy
+∞
19.4
19
*
Z94.0
ICD-10 Finland
Kidney transplant status
5.3
19.4
60
109
SPAT1263
SPAT
Sampling
1.3
19.2
1793
14030
R5120
NOMESCO Finland
Preparation of an aid
4.0
19.1
77
183
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.2
19.1
102
305
DC1BD
NOMESCO Finland
Temporal bone extensive CT
189.6
19.1
20
*
J32.4
ICD-10 Finland
Chronic pansinusitis
4.5
19.1
68
144
R06.0
ICD-10 Finland
Dyspnoea
1.5
18.9
700
4616
L04AA06
ATC
mycophenolic acid; systemic
4.0
18.8
77
186
602
Kela drug reimbursment
Children's severe malnutrition
5.9
18.8
53
86
H60.4
ICD-10 Finland
Cholesteatoma of external ear
19.0
18.4
28
14
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
18.4
748
5028
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.9
18.4
77
190
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
18.4
18
*
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
18.4
18
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
18.3
675
4444
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
18.3
218
1014
A02BC02
ATC
pantoprazole; systemic
1.3
18.3
1864
14749
H61.2
ICD-10 Finland
Impacted cerumen
2.2
18.2
187
815
M25.5
ICD-10 Finland
Pain in joint
1.4
18.2
949
6710
H70
ICPC
Otitis externa
3.1
18.1
103
320
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.5
18.0
710
4742
R74
ICPC
Upper respiratory infection acute
1.4
17.9
1495
11456
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
17.9
386
2215
H73.0
ICD-10 Finland
Acute myringitis
7.8
17.8
41
50
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.2
17.8
55
100
ZXD05
NOMESCO Finland
Urgent procedure
1.4
17.8
1033
7444
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
17.7
928
6561
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
17.7
540
3401
N03AX16
ATC
pregabalin; oral
1.5
17.5
600
3881
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
17.5
1220
9074
R96
ICPC
Asthma
1.8
17.4
304
1633
A02BC01
ATC
omeprazole; systemic
1.5
17.3
746
5073
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
17.1
17.2
27
15
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
17.2
277
1450
WX110
NOMESCO Finland
Local anesthesy
1.3
17.1
2930
24900
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
17.0
2348
19334
UDM02
NOMESCO Finland
Sinoscopy
3.3
16.9
87
254
Z3231
NOMESCO Finland
Registered nurse
1.4
16.9
940
6714
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.3
16.8
152
626
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
16.7
896
6352
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
16.5
1055
7715
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
16.5
2233
18305
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
16.4
904
6438
DCA40
NOMESCO Finland
Fat patching or other similar technique without opening of tympanic membrane
+∞
16.3
16
*
4144
FHL
Mastoidectomy or aticomastoidectomy
+∞
16.3
16
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.0
16.2
214
1040
H60.1
ICD-10 Finland
Cellulitis of external ear
3.8
16.1
68
170
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
16.0
509
3234
R03CC03
ATC
terbutaline; systemic
2.0
16.0
210
1017
R11
ICD-10 Finland
Nausea and vomiting
1.7
16.0
325
1831
M54.5
ICD-10 Finland
Low back pain
1.4
15.5
1085
8042
XQ800
NOMESCO Finland
Prick test
1.7
15.5
344
1992
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
15.5
284
1551
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.8
15.3
101
350
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
15.3
454
2834
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
+∞
15.3
15
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
15.3
669
4555
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
15.3
1748
13942
R05
ICD-10 Finland
Cough
1.5
15.3
650
4402
A08.0
ICD-10 Finland
Rotaviral enteritis
3.7
15.2
66
169
ZXA05
NOMESCO Finland
Left side
1.5
15.2
611
4087
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
80.6
15.2
17
*
J45
ICD-10 Finland
Asthma
1.7
15.1
330
1900
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.7
15.1
102
359
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.4
15.1
126
499
Z71.8
ICD-10 Finland
Other specified counselling
1.4
15.0
992
7275
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.7
15.0
103
366
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
15.0
1277
9752
N05BA01
ATC
diazepam; systemic, rectal
1.6
14.9
368
2192
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.0
14.9
86
274
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
14.8
423
2614
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
14.8
1627
12889
S06.0
ICD-10 Finland
Concussion
1.6
14.7
437
2731
H27
ICPC
Fear of ear disease
3.6
14.6
66
175
R06AX27
ATC
desloratadine; oral
1.3
14.6
1132
8512
G47.3
ICD-10 Finland
Sleep apnoea
1.5
14.6
478
3053
A03
ICPC
Fever
1.4
14.6
882
6373
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.8
14.5
48
95
SPAT1310
SPAT
Counselling related to known health issue
1.3
14.5
1395
10840
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
4.2
14.4
55
126
L03
ICPC
Low back symptom/complaint
1.4
14.4
898
6519
BE00A
NOMESCO Finland
NA
30.0
14.4
19
6
L17
ICPC
Foot/toe symptom/complaint
1.4
14.3
949
6956
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
+∞
14.3
14
*
Z2446
NOMESCO Finland
Social worker
1.7
14.3
289
1629
H60.0
ICD-10 Finland
Abscess of external ear
5.2
14.2
44
81
H72
ICD-10 Finland
Perforation of tympanic membrane
19.9
14.2
21
10
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
4.6
14.2
49
102
SPAT1301
SPAT
No procedures
1.3
14.1
1230
9405
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
2.9
14.1
87
289
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
14.1
154
693
R62.0
ICD-10 Finland
Delayed milestone
3.6
14.1
64
171
R21
ICPC
Throat symptom/complaint
1.3
13.9
1262
9704
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
13.9
375
2288
P01AB01
ATC
metronidazole; oral, rectal
1.3
13.8
1170
8904
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
13.8
359
2168
S18
ICPC
Laceration/cut
1.3
13.7
1293
9996
WX290
NOMESCO Finland
Other blockade of nerve
1.3
13.7
2027
16641
SPAT1262
SPAT
Handing over of treatment supplies
1.5
13.7
431
2730
E66.8
ICD-10 Finland
Other obesity
2.1
13.6
162
757
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
13.6
267
1490
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
13.5
541
3610
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
13.5
321
1894
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
13.3
13
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
13.2
457
2956
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
13.0
173
845
UKC02
NOMESCO Finland
Cystoscopy
1.6
13.0
329
1969
-1
NOMESCO Finland
NA
1.3
13.0
1772
14364
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
13.0
282
1621
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
13.0
219
1164
A01AB09
ATC
miconazole; local oral
1.7
12.9
266
1505
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
8.8
12.9
27
29
ZXD20
NOMESCO Finland
Day surgery
1.6
12.9
375
2331
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.1
12.8
70
216
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.7
1893
15498
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
12.7
648
4527
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
12.7
1103
8406
N30.0
ICD-10 Finland
Acute cystitis
1.5
12.7
500
3325
UJF32
NOMESCO Finland
Coloscopy
1.4
12.5
602
4163
J01EA01
ATC
trimethoprim; systemic
1.4
12.5
779
5643
H02
ICPC
Hearing complaint
1.7
12.4
258
1464
G44.2
ICD-10 Finland
Tension-type headache
1.5
12.3
470
3106
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
12.2
916
6825
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
12.1
208
1114
R03BB04
ATC
tiotropium bromide; inhalant
1.9
12.1
185
950
J01FA06
ATC
roxithromycin; oral
1.3
12.1
1092
8363
R03BA01
ATC
beclometasone; inhalant
1.6
12.0
359
2246
N06AX11
ATC
mirtazapine; oral
1.3
11.9
934
7001
R02
ICPC
Shortness of breath/dyspnoea
1.5
11.9
381
2420
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.9
678
4831
WX002
NOMESCO Finland
Sedation and analgesia
1.5
11.8
491
3298
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.8
11.8
74
251
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
11.8
556
3831
L04AA01
ATC
[U] ciclosporin; systemic
3.7
11.7
50
128
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.4
11.7
520
3543
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
11.7
267
1557
SPAT1044
SPAT
Tympanometry
2.3
11.6
106
440
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.5
11.6
54
149
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
11.6
3101
27100
R07.3
ICD-10 Finland
Other chest pain
1.7
11.5
246
1406
L12
ICPC
Hand/finger symptom/complaint
1.4
11.5
640
4538
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
11.5
225
1254
J01MA14
ATC
moxifloxacin; systemic
1.8
11.5
208
1135
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
4.6
11.5
39
81
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
11.5
265
1550
F83
ICD-10 Finland
Mixed specific developmental disorders
3.0
11.4
65
205
Z00.0
ICD-10 Finland
General medical examination
1.4
11.3
752
5495
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.2
11.3
114
497
H70.9
ICD-10 Finland
Mastoiditis, unspecified
+∞
11.2
11
*
38400
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta
+∞
11.2
11
*
H73.8
ICD-10 Finland
Other specified disorders of tympanic membrane
21.7
11.2
16
7
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.4
11.1
91
357
R03AC12
ATC
salmeterol; inhalant
2.2
11.1
108
462
R06AE09
ATC
levocetirizine; oral
1.4
11.1
559
3893
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
11.1
88
341
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
11.1
153
758
J01DC04
ATC
cefaclor; oral
2.7
11.1
75
267
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
11.1
898
6760
N01
ICPC
Headache
1.3
11.1
846
6314
J20
ICD-10 Finland
Acute bronchitis
1.6
11.0
281
1692
R06AX13
ATC
loratadine; oral
1.4
11.0
553
3856
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
11.0
440
2936
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
11.0
481
3267
AA1AD
NOMESCO Finland
CT of head and brain
1.4
10.9
526
3632
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
10.9
203
1117
N05AH04
ATC
quetiapine; oral
1.4
10.9
641
4588
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
10.8
295
1801
R05FB02
ATC
cough suppressants and expectorants
1.3
10.8
851
6376
H69.9
ICD-10 Finland
Eustachian tube disorder, unspecified
8.4
10.8
23
26
R01AD11
ATC
triamcinolone; nasal
1.6
10.8
250
1464
UGC02
NOMESCO Finland
Rigid bronchoscopy
5.7
10.7
30
50
N07CA01
ATC
betahistine; oral
1.9
10.7
152
761
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.5
10.7
337
2132
N06AX16
ATC
venlafaxine; oral
1.4
10.7
461
3117
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
4.1
10.7
40
92
R01AD01
ATC
beclometasone; nasal
1.5
10.7
397
2606
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
10.6
149
744
H02AB09
ATC
hydrocortisone; systemic
2.3
10.6
96
398
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.5
10.5
320
2013
SBB10
NOMESCO Finland
Teeth copy
1.4
10.4
522
3628
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
10.4
152
772
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
26.5
10.4
14
5
FM2CE
NOMESCO Finland
NA
3.0
10.4
60
193
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
56.8
10.4
12
*
EBA00
NOMESCO Finland
Extraction of tooth
1.3
10.3
1381
11083
XF622
NOMESCO Finland
Measurement of minute volume of heart
8.3
10.3
22
25
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
10.3
242
1423
B03XA01
ATC
erythropoietin; parenteral
5.4
10.3
30
53
R01AD05
ATC
budesonide; nasal
1.7
10.2
206
1162
N05BA04
ATC
oxazepam; oral
1.3
10.1
708
5206
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.9
10.1
59
192
J03.0
ICD-10 Finland
Streptococcal tonsillitis
1.7
10.1
207
1173
Q20.48
ICD-10 Finland
Single ventricle
30.8
10.0
13
*
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
4.1
10.0
38
89
J01FA15
ATC
telithromycin; oral
1.6
9.9
240
1422
J33.8
ICD-10 Finland
Other polyp of sinus
3.0
9.9
57
183
X58
ICD-10 Finland
Exposure to other specified factors
1.4
9.9
509
3559
C03CA01
ATC
furosemide; systemic
1.4
9.9
464
3191
N03AX12
ATC
gabapentin; oral
1.5
9.9
362
2371
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.7
9.9
32
64
A02BC05
ATC
esomeprazole; systemic
1.3
9.8
1017
7898
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
9.8
676
4958
J30.3
ICD-10 Finland
Other allergic rhinitis
1.8
9.8
155
810
L01
ICPC
Neck symptom/complaint
1.4
9.8
492
3421
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
9.8
312
1981
S29
ICPC
Skin symptom/complaint other
1.4
9.8
572
4087
SPAT1254
SPAT
Administration of medicine
1.3
9.7
738
5489
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
9.7
103
460
H69.8
ICD-10 Finland
Other specified disorders of Eustachian tube
7.0
9.7
23
31
T82
ICPC
Obesity
1.9
9.7
132
654
L04AD01
ATC
ciclosporin; systemic
2.6
9.7
69
253
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
9.7
647
4724
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
9.6
463
3197
S80.0
ICD-10 Finland
Contusion of knee
1.6
9.6
251
1521
L15
ICPC
Knee symptom/complaint
1.3
9.6
749
5595
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
9.6
211
1222
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
9.5
272
1684
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
9.5
258
1576
DHB20
NOMESCO Finland
Polypectomy of internal nose
3.4
9.5
44
122
J47
ICD-10 Finland
Bronchiectasis
3.4
9.5
45
127
ZX120
NOMESCO Finland
Intravenous
1.6
9.5
250
1518
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
9.5
154
813
H02AB07
ATC
prednisone; oral
1.5
9.5
329
2130
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.4
9.5
503
3537
R03AK08
ATC
formoterol and beclometasone; inhalant
2.1
9.5
99
441
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
2.5
9.4
74
286
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
9.4
201
1154
R06.5
ICD-10 Finland
Mouth breathing
1.6
9.4
232
1385
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
52.0
9.4
11
*
C01CA24
ATC
epinephrine; parenteral
1.6
9.4
261
1603
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
2.2
9.4
96
423
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
9.4
270
1677
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
9.3
781
5890
Z2221
NOMESCO Finland
Medical doctor
1.3
9.3
863
6600
H81.3
ICD-10 Finland
Other peripheral vertigo
2.7
9.3
63
226
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
9.3
865
6621
RD210
NOMESCO Finland
NA
2.1
9.3
98
440
J02AC01
ATC
fluconazole; systemic
1.3
9.2
1198
9551
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
9.2
202
1170
M31.3
ICD-10 Finland
Wegener granulomatosis
7.4
9.2
21
27
B01.9
ICD-10 Finland
Varicella without complication
3.5
9.2
41
111
4145
FHL
Tympanomastoidectomy, includes possible tympanoplasty
+∞
9.2
9
*
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.1
9.1
49
152
Z96.2
ICD-10 Finland
Presence of otological and audiological implants
28.4
9.1
12
*
Z3226
NOMESCO Finland
Physiotherapist
1.4
9.1
539
3855
SPAT1043
SPAT
Audiometry
1.5
9.1
273
1709
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.4
9.1
76
306
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
9.1
780
5901
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
9.1
55
185
61
HP
Catheterization and pressure measurement of the left side of the heart
3.6
9.0
39
103
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.8
9.0
54
181
-69
ICPC
Other reason for encounter NEC
1.9
9.0
128
646
R07.0
ICD-10 Finland
Pain in throat
1.5
8.9
280
1770
5AB14
NOMESCO Finland
NA
10.1
8.9
17
16
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.5
8.9
30
63
31
HP
Congenital heart failure surgery
4.7
8.9
29
59
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
8.9
161
881
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
8.8
235
1431
A02BC03
ATC
lansoprazole; oral
1.3
8.8
621
4568
A04
ICPC
Weakness/tiredness general
1.3
8.8
576
4187
SPAT1283
SPAT
Restricted health certificate
1.3
8.8
1045
8240
R56.0
ICD-10 Finland
Febrile convulsions
2.6
8.8
60
216
Z2445
NOMESCO Finland
Psychologist
1.6
8.8
225
1355
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
8.8
1118
8887
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
6.9
8.8
21
29
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
34.7
8.8
11
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.2
8.7
32
73
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.7
8.7
184
1053
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
8.7
218
1304
S02AA30
ATC
antiinfectives, combinations; otic
1.6
8.7
210
1244
F90.0
ICD-10 Finland
Disturbance of activity and attention
1.6
8.7
207
1226
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
8.7
149
802
A03FA02
ATC
cisapride; oral, rectal
1.7
8.7
182
1042
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
8.6
373
2525
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
2.7
8.6
55
191
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
8.6
237
1457
T07
ICPC
Weight gain
2.3
8.6
73
298
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
8.6
194
1133
A06AD11
ATC
lactulose; oral
1.5
8.5
300
1946
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
4.1
8.5
32
75
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
8.5
224
1362
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
6.1
8.5
22
34
F80.1
ICD-10 Finland
Expressive language disorder
2.7
8.5
55
193
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
47.3
8.5
10
*
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
4.6
8.5
28
58
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
8.4
385
2631
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.0
8.4
103
492
R52.9
ICD-10 Finland
Pain, unspecified
1.5
8.4
247
1539
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
8.4
155
853
N06AB10
ATC
escitalopram; oral
1.3
8.4
765
5830
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
1.8
8.4
151
825
J34.2
ICD-10 Finland
Deviated nasal septum
1.8
8.4
135
714
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.5
8.3
64
246
L20.0
ICD-10 Finland
Besnier prurigo
1.4
8.3
394
2715
N06AA09
ATC
amitriptyline; systemic
1.6
8.3
198
1174
L16
ICPC
Ankle symptom/complaint
1.4
8.3
462
3275
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
8.3
284
1836
T16
ICD-10 Finland
Foreign body in ear
3.1
8.3
44
137
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.5
8.3
322
2136
Z99.2
ICD-10 Finland
Dependence on renal dialysis
10.9
8.2
15
13
H77
ICPC
Perforation ear drum
26.0
8.2
11
*
H74.0
ICD-10 Finland
Tympanosclerosis
85.2
8.2
9
*
UJD02
NOMESCO Finland
Gastroscopy
1.9
8.2
112
558
F43.8
ICD-10 Finland
Other reactions to severe stress
2.1
8.2
93
432
N06AA12
ATC
doxepin; systemic
1.9
8.2
108
532
WX704
NOMESCO Finland
Intubation
1.6
8.2
195
1154
U07
ICPC
Urine symptom/complaint other
1.7
8.2
153
848
3824A
ICD-9 Finland
Suppurative and unspecified otitis media, Unspecified suppurative otitis media
+∞
8.2
8
*
H74
ICPC
Chronic otitis media
+∞
8.2
8
*
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
4.7
8.1
26
52
R01BA01
ATC
phenylpropanolamine; oral
1.8
8.1
129
677
J06.80
ICD-10 Finland
Continuously repeating infections of a child
6.5
8.1
20
29
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
4.0
8.1
31
74
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
8.1
138
741
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
8.1
78
338
L04AX01
ATC
azathioprine; systemic
1.8
8.1
145
793
Q35.1
ICD-10 Finland
Cleft hard palate
12.1
8.1
14
11
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.4
8.0
65
256
R04.0
ICD-10 Finland
Epistaxis
1.7
8.0
162
915
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
8.0
278
1802
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
8.0
235
1467
L01AA01
ATC
cyclophosphamide; systemic
10.1
8.0
15
14
Z50.5
ICD-10 Finland
Speech therapy
2.5
8.0
60
231
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
7.9
300
1980
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.4
7.9
65
260
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
7.9
161
913
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
7.9
147
814
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
7.9
111
559
E0000UV
ATC
NA
1.2
7.9
1478
12224
183
Kela drug reimbursment
Lamotrigin and topiramate
2.8
7.9
47
158
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
31.5
7.9
10
*
XF602
NOMESCO Finland
Bloodpressure monitoring
3.1
7.9
40
121
A01
ICPC
Pain general/multiple sites
1.5
7.8
232
1452
SPAT1315
SPAT
Periodic health check-up of children and adolescents
1.2
7.8
1216
9860
N05CF02
ATC
zolpidem; oral
1.4
7.8
420
2957
ZXC10
NOMESCO Finland
Use of laser
2.5
7.8
58
221
137
Kela drug reimbursment
Uraemia requiring dialysis
4.0
7.8
29
68
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
7.8
397
2772
M54.2
ICD-10 Finland
Cervicalgia
1.6
7.7
190
1134
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
7.7
547
4025
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.9
7.7
106
531
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.1
7.7
23
43
K04.0
ICD-10 Finland
Pulpitis
1.4
7.7
341
2321
P01
ICPC
Feeling anxious/nervous/tense
1.3
7.7
746
5729
WX882
NOMESCO Finland
High dependency care
2.0
7.7
89
419
WW200
NOMESCO Finland
Immunization
2.0
7.6
91
432
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
2.0
7.6
88
411
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
2.8
7.6
46
156
R1260
NOMESCO Finland
Evaluation of communicative skills
2.9
7.6
44
144
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.2
7.6
1271
10378
B05DA
ATC
Isotonic solutions
4.6
7.6
25
52
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
6.8
7.6
18
25
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.1
7.6
79
355
N06AB04
ATC
citalopram; systemic
1.3
7.6
531
3897
A11CC03
ATC
alfacalcidol; systemic
2.5
7.6
56
212
K03.66
ICD-10 Finland
Tooth plaque
1.5
7.5
268
1746
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
7.5
259
1675
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
7.5
1363
11217
120
Kela drug reimbursment
Hypogammaglobulinaemia
8.9
7.5
15
16
L27.2
ICD-10 Finland
Dermatitis due to ingested food
1.9
7.4
102
512
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.4
7.4
445
3190
Z94.4
ICD-10 Finland
Liver transplant status
6.6
7.4
18
26
N06BA04
ATC
methylphenidate; oral
1.7
7.4
158
912
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
7.4
330
2248
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
7.4
91
438
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.4
7.4
61
246
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
23.6
7.3
10
*
SPAT1307
SPAT
Psychosocial counselling and guidance
1.3
7.3
487
3546
62
HP
Catheterization and pressure measurement of the right side of the heart
6.0
7.3
19
30
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
7.3
262
1708
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.6
7.3
51
188
B05DB
ATC
Hypertonic solutions
5.0
7.3
22
42
F82
ICD-10 Finland
Specific developmental disorder of motor function
2.8
7.3
44
150
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.0
7.2
85
399
7490A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
75.7
7.2
8
*
FBA96
NOMESCO Finland
Other suture or repair of pulmonary artery
75.7
7.2
8
*
D01
ICPC
Abdominal pain/cramps general
1.3
7.2
535
3956
TFJ02
NOMESCO Finland
Muscle biopsy of heart
9.5
7.2
14
14
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.0
7.2
90
436
H01AC01
ATC
somatropin; parenteral
3.6
7.2
30
78
J35.0
ICD-10 Finland
Chronic tonsillitis
1.5
7.2
255
1658
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.2
576
4309
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
1.8
7.2
113
592
ZY010
NOMESCO Finland
Hospital outpatient
1.5
7.2
249
1615
SPAT1211
SPAT
Application of soft bandage
1.4
7.2
384
2704
N03AF02
ATC
oxcarbazepine; oral
1.9
7.1
105
537
D07AA02
ATC
hydrocortisone; topical
1.3
7.1
580
4349
H74.4
ICD-10 Finland
Polyp of middle ear
+∞
7.1
7
*
3813X
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Other and unspecified chronic nonsuppurative otitis media
+∞
7.1
7
*
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
+∞
7.1
7
*
4364
FHL
Pharyngeal tongue plastic
+∞
7.1
7
*
Z97.8
ICD-10 Finland
Presence of other specified devices
5.1
7.1
21
39
D19
ICPC
Teeth/gum symptom/complaint
1.2
7.1
1024
8221
R06AX22
ATC
ebastine; oral
1.3
7.1
467
3397
48609
ICD-8 Finland
Pneumonia, unspecified
3.0
7.1
38
120
A07AA02
ATC
nystatin; oral
1.7
7.1
129
710
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
7.1
808
6322
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
7.0
472
3445
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
7.0
167
990
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.5
7.0
197
1220
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
7.0
267
1765
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
10.3
7.0
13
12
J01.4
ICD-10 Finland
Acute pansinusitis
3.3
7.0
33
95
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
7.0
511
3773
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
7.0
278
1856
N05CF01
ATC
zopiclone; oral
1.3
7.0
696
5359
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
5.3
7.0
20
36
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
7.0
106
552
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
7.0
163
962
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.4
7.0
53
206
UDC10
NOMESCO Finland
Tympanoscopy
28.4
6.9
9
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
6.9
202
1260
N03AG01
ATC
valproic acid; systemic, rectal
1.6
6.9
182
1107
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.3
6.9
777
6066
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.0
6.9
85
409
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
18.9
6.9
10
5
R06.4
ICD-10 Finland
Hyperventilation
2.2
6.9
64
274
D06
ICPC
Abdominal pain localized other
1.4
6.9
319
2189
K59.0
ICD-10 Finland
Constipation
1.6
6.9
159
936
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
6.9
198
1231
R83
ICPC
Respiratory infection other
1.2
6.9
1187
9708
K56.0
ICD-10 Finland
Paralytic ileus
4.9
6.8
21
41
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.8
259
1712
1450
FHL
Otomicroscopy
4.2
6.8
24
54
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
6.8
135
762
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
6.8
303
2064
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.7
6.8
142
815
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.7
6.8
121
662
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.8
6.8
119
647
H65
ICD-10 Finland
Nonsuppurative otitis media
2.8
6.8
40
134
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.3
6.8
57
231
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.8
1178
9638
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
6.8
54
214
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
8.3
6.8
14
16
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
6.8
481
3541
R09
ICPC
Sinus symptom/complaint
1.4
6.7
287
1937
D10
ICPC
Vomiting
1.4
6.7
326
2254
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.5
6.7
243
1590
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
6.7
132
744
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
6.7
428
3101
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.7
6.6
135
769
SPAT1316
SPAT
Extensive health check-up of children and adolescents
1.2
6.6
811
6394
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
1.8
6.6
103
541
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
6.6
232
1509
R35
ICD-10 Finland
Polyuria
1.7
6.6
133
753
S02AA03
ATC
boric acid; otic
3.8
6.6
26
65
K07.60
ICD-10 Finland
Snapping jaw
1.5
6.6
186
1152
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.5
6.6
239
1564
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
6.6
198
1245
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
37.8
6.6
8
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.2
6.6
61
260
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.5
522
3904
W19
ICD-10 Finland
Unspecified fall
1.4
6.5
302
2071
T90
ICPC
Diabetes non-insulin dependent
1.3
6.5
389
2787
4741B
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]
2.4
6.5
50
195
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
6.5
244
1609
L50.9
ICD-10 Finland
Urticaria, unspecified
1.6
6.5
149
875
ZZG00
NOMESCO Finland
Graft of cartilage
7.8
6.5
14
17
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.5
6.5
238
1559
M31.1
ICD-10 Finland
Thrombotic microangiopathy
15.8
6.5
10
6
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.2
6.5
64
282
H16.0
ICD-10 Finland
Corneal ulcer
1.7
6.5
129
730
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
6.5
332
2317
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
21.3
6.5
9
*
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
21.3
6.5
9
*
49300
ICD-8 Finland
Asthma, bronchiale
2.6
6.5
44
162
OIKK
NOMESCO Finland
NA
1.4
6.5
353
2495
ZX108
NOMESCO Finland
Inhalation
3.4
6.5
29
81
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
6.4
373
2662
M79.1
ICD-10 Finland
Myalgia
1.3
6.4
406
2938
L29.9
ICD-10 Finland
Pruritus, unspecified
2.1
6.4
65
289
R03BB01
ATC
ipratropium bromide; inhalant
2.2
6.4
63
278
C08CA01
ATC
amlodipine; oral
1.3
6.4
582
4431
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
6.4
136
787
SPAT1039
SPAT
Otomicroscopy
2.0
6.3
74
349
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.4
6.3
287
1961
Z94.1
ICD-10 Finland
Heart transplant status
7.4
6.3
14
18
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.4
6.3
21
45
RS211
NOMESCO Finland
NA
3.2
6.3
30
88
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
3.3
6.3
29
83
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.3
6.3
55
231
R75
ICPC
Sinusitis acute/chronic
1.6
6.3
145
857
J01
ICD-10 Finland
Acute sinusitis
1.6
6.3
164
1000
4151
FHL
Reoperation for chronic otitis media
66.0
6.3
7
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.2
519
3903
VALMI
NOMESCO Finland
NA
1.2
6.2
1285
10671
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.2
6.2
57
244
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.7
6.2
25
64
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.2
2314
20196
J01FA01
ATC
erythromycin; systemic
1.3
6.2
463
3430
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
6.2
78
382
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
6.2
1371
11454
RK320
NOMESCO Finland
NA
4.0
6.2
23
55
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
13.5
6.2
10
7
SGA01
NOMESCO Finland
Tooth opening as first aid
1.3
6.2
503
3771
R51
ICD-10 Finland
Headache
1.5
6.2
196
1249
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.5
6.2
181
1132
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
6.2
166
1020
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.1
524
3957
4148
FHL
Radical cutting and cavity filling
+∞
6.1
6
*
3811A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media
+∞
6.1
6
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
5.0
6.1
18
34
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
6.1
285
1959
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
6.1
329
2321
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.0
6.1
70
329
0601
NOMESCO Finland
NA
17.0
6.1
9
5
304
Kela drug reimbursment
Dornase alfa
25.2
6.1
8
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
25.2
6.1
8
*
A12AA04
ATC
calcium carbonate; oral
2.9
6.0
35
116
Z94.2
ICD-10 Finland
Lung transplant status
8.7
6.0
12
13
E66.00
ICD-10 Finland
Metabolic syndrome
1.7
6.0
109
603
A46
ICD-10 Finland
Erysipelas
1.4
6.0
261
1773

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
943
4031
2.40
113.99
2.3
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1930
12838
1.60
54.34
7.6
6.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
522
2548
1.98
42.52
8.3
5.2
kpa
5.0
5.1
0.93
490
2412
(3009343) pH of Capillary blood
518
2534
1.98
41.91
8.3
5.2
ph
7.4
7.4
1.27
59
215
(3022096) Basophils/100 leukocytes in Blood
2416
17565
1.49
41.82
8.0
6.1
%
0.6
0.7
0.42
2267
16460
(3006504) Eosinophils/100 leukocytes in Blood
2493
18241
1.48
41.78
7.9
6.0
%
2.9
2.8
0.36
2344
17069
(3019069) Monocytes/100 leukocytes in Blood
2503
18353
1.48
41.35
8.1
6.3
%
8.2
8.2
0.21
2357
17266
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
508
2483
1.98
41.17
8.3
5.3
mmol/l
0.9
1.3
1.59
366
1771
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2141
15329
1.48
39.20
9.1
6.5
mmol/l
1.2
1.2
1.65
1847
13089
(3002030) Lymphocytes/100 leukocytes in Blood
2591
19265
1.46
38.97
7.8
6.0
%
31.1
30.7
0.86
2439
18096
(3013115) Eosinophils [#/volume] in Blood
2659
19977
1.45
37.16
8.3
6.3
e9/l
0.2
0.2
0.78
2363
17599
(3001604) Monocytes [#/volume] in Blood
2576
19263
1.45
36.75
7.9
6.0
e9/l
0.6
0.6
3.01
2252
16666
(3006315) Basophils [#/volume] in Blood
2579
19306
1.44
36.48
7.8
6.0
e9/l
0.0
0.0
1.94
2257
16694
(3018010) Neutrophils/100 leukocytes in Blood
2539
18966
1.44
36.24
7.6
5.8
%
54.5
54.9
1.08
2402
17858
(3028626) Oxygen [Partial pressure] in Capillary blood
347
1548
2.14
35.92
9.9
6.2
kpa
9.6
9.4
1.42
329
1477
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1955
13935
1.46
35.63
8.9
6.3
mmol/l
1.2
1.2
2.33
1794
12757
(3019198) Lymphocytes [#/volume] in Blood
2659
20135
1.43
34.59
7.8
5.9
e9/l
2.1
2.1
1.12
2381
17822
(3013826) Glucose [Moles/volume] in Serum or Plasma
2602
19668
1.42
33.93
5.7
4.7
mmol/l
6.4
6.3
0.53
2404
17882
(3026250) Tacrolimus [Mass/volume] in Blood
80
163
4.57
32.67
46.7
37.0
ug/l
6.9
7.2
0.72
73
152
(3013650) Neutrophils [#/volume] in Blood by Automated count
2854
22076
1.41
31.74
9.9
8.4
e9/l
4.0
3.9
0.29
2478
19165
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1884
13553
1.43
31.67
2.1
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
387
1889
1.95
31.26
8.9
5.8
mmol/l
24.1
24.3
1.44
380
1828
(3042936) Bacteria identified in Isolate by Culture
723
4256
1.65
31.04
2.1
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2165
16008
1.41
30.99
5.9
5.6
umol/l
11.8
11.8
0.00
2044
14942
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
278
1207
2.18
30.79
14.1
8.5
mg/l
1.3
1.2
0.80
266
1156
(3013707) Erythrocyte sedimentation rate by Westergren method
3310
26345
1.41
30.70
5.0
3.7
mm/h
9.5
9.4
0.17
3079
24418
(3022313) Gas panel - Capillary blood
398
1979
1.92
30.43
9.1
5.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1456
10043
1.46
30.40
2.9
2.4
u/l
55.0
56.4
0.28
1355
9265
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3201
25365
1.40
30.21
7.5
6.4
u/l
82.8
79.2
3.34
3011
23822
(3005719) IgG [Mass/volume] in Serum or Plasma
529
2905
1.75
29.29
3.7
2.6
g/l
10.1
10.4
0.86
494
2678
(3003458) Phosphate [Moles/volume] in Serum or Plasma
721
4337
1.61
28.21
9.8
6.4
mmol/l
1.1
1.1
1.14
681
4070
(3000850) Epithelial cells [#/volume] in Urine
1069
7025
1.50
28.16
3.4
2.4
e6/l
7.6
7.4
0.08
944
6150
(3032080) INR in Blood by Coagulation assay
1523
10721
1.43
28.07
6.5
6.8
inr
1.1
1.1
1.32
526
3539
(3000494) Fungus identified in Specimen by Culture
642
3759
1.65
27.98
1.8
1.4
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
31
26
11.03
27.93
5.5
7.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2327
17666
1.38
27.30
10.6
8.3
e9/l
0.0
0.0
0.04
1920
14259
(3026782) Osmolality of Urine
1006
6604
1.50
26.44
3.5
2.5
mosm/kgh2o
559.7
565.6
0.32
876
5632
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
42
57
6.83
26.27
7.7
7.0
mg/l
2.7
2.4
0.34
36
47
(3005322) IgE [Units/volume] in Serum or Plasma
537
3052
1.69
26.15
1.4
1.3
u/ml
255.6
280.8
0.19
500
2808
(3023103) Potassium [Moles/volume] in Serum or Plasma
4371
37013
1.48
25.52
15.1
11.3
mmol/l
3.9
3.9
0.71
4247
35700
(3019550) Sodium [Moles/volume] in Serum or Plasma
4362
36948
1.47
25.16
15.0
11.2
mmol/l
139.6
139.5
0.47
4254
35741
(3002032) Base excess in Venous blood by calculation
576
3396
1.63
24.25
7.6
5.3
mmol/l
1.4
1.6
0.67
469
2693
(3021447) Carbon dioxide [Partial pressure] in Venous blood
578
3416
1.62
24.10
7.6
5.2
kpa
5.9
5.8
1.44
556
3317
(40758558) Short blood count panel - Blood
1327
9376
1.40
23.11
7.7
6.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
389
2102
1.76
22.64
5.9
4.3
ng/l
68.2
73.9
1.00
350
1885
(3037467) Urinalysis macro (dipstick) panel - Urine
3172
25696
1.33
22.30
5.1
3.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4584
39440
1.49
22.06
14.5
10.5
mg/l
20.5
21.8
1.92
3618
29342
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
755
4834
1.51
22.03
2.1
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1406
10113
1.38
21.78
1.6
1.4
g/l
2.0
2.1
0.73
857
6149
(3018418) pH of Serum or Plasma
1231
8664
1.40
21.72
4.5
3.6
ph
7.4
7.4
0.45
242
1668
(3002179) Metamyelocytes/100 leukocytes in Blood
454
2593
1.67
21.58
4.5
3.9
%
0.7
0.5
0.28
109
525
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
31
38
7.55
21.17
4.8
5.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
31
38
7.55
21.17
5.2
5.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1430
10353
1.37
21.16
4.1
3.0
e6/l
31.1
101.3
3.07
1148
7718
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
412
2308
1.70
21.05
7.6
5.8
mmol/l
23.9
23.9
0.04
385
2178
(3011412) CD3 cells [#/volume] in Blood
119
420
2.64
20.94
3.0
2.6
e9/l
1.4
1.3
0.58
82
246
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
44
79
5.16
20.88
6.9
6.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
401
2241
1.70
20.67
2.2
1.8
g/l
1.2
1.3
0.44
378
2098
(3026008) Bacteria identified in Urine by Culture
1434
10430
1.36
20.49
3.0
2.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
499
2964
1.61
20.26
7.8
5.1
kpa
4.9
4.9
0.05
484
2878
(3015235) Bicarbonate [Moles/volume] in Capillary blood
174
746
2.19
19.94
5.0
3.3
mmol/l
23.7
24.2
0.89
153
672
(3024139) IgG subclass 3 [Mass/volume] in Serum
111
389
2.66
19.83
1.4
1.3
g/l
0.4
0.4
0.01
78
287
(3028192) IgG subclass 2 [Mass/volume] in Serum
111
389
2.66
19.83
1.4
1.3
g/l
2.5
2.8
0.97
79
290
(3027135) IgG subclass 1 [Mass/volume] in Serum
111
390
2.65
19.73
1.4
1.3
g/l
5.7
6.7
3.40
78
291
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
101
339
2.78
19.60
3.7
3.5
%
88.0
95.7
1.85
96
321
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
100
334
2.79
19.59
3.1
2.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1312
9470
1.36
19.51
4.1
2.9
e6/l
0.3
0.4
0.42
1027
6947
(3020779) Urea [Moles/volume] in Serum or Plasma
459
2698
1.62
19.43
12.4
8.1
mmol/l
7.5
7.4
0.13
445
2609
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
1.1
3.0
1.01
21
34
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
1.6
1.2
0.24
19
35
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
1.1
1.6
0.40
23
36
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
1.3
0.9
0.41
22
31
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
2.7
1.9
0.23
20
36
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
1.1
2.4
0.63
24
36
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
4.0
4.6
0.15
22
34
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
0.7
1.9
1.25
20
30
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
32
45
6.58
19.40
1.8
1.7
mg/l
3.3
3.8
0.14
19
28
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1373
9999
1.36
19.24
3.3
2.9
ng/l
29.1
66.5
1.01
739
5211
(3025159) Blasts/100 leukocytes in Blood
440
2572
1.63
19.04
5.1
4.3
%
0.1
0.3
0.72
114
566
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
32
46
6.44
19.01
1.8
1.8
mg/l
0.9
0.9
0.04
20
36
(3021440) Promyelocytes/100 leukocytes in Blood
456
2693
1.61
18.93
5.1
4.3
%
0.1
0.1
0.38
129
659
(3017181) Myelocytes/100 leukocytes in Blood
473
2821
1.60
18.84
5.0
4.2
%
0.5
0.8
1.18
137
712
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1563
11642
1.33
18.74
4.1
3.2
u/l
30.2
32.9
0.96
1496
11091
(4062490)
110
395
2.60
18.74
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1569
11694
1.33
18.73
1.5
1.4
u/ml
1.5
1.9
1.19
381
2957
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1068
7500
1.39
18.72
2.5
2.0
mg/l
1.2
1.1
0.27
759
5320
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
99
341
2.70
18.32
2.9
2.6
e9/l
0.2
0.2
0.44
85
269
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
770
5127
1.45
18.20
4.2
3.2
ng/l
237.4
472.5
2.82
454
3150
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
148
621
2.23
17.91
9.0
4.2
u/ml
366.1
1362.8
0.93
19
41
(3018677) aPTT in Platelet poor plasma by Coagulation assay
704
4632
1.46
17.68
4.2
2.8
s
30.2
29.7
1.22
680
4488
(3023368) Bacteria identified in Blood by Culture
1073
7604
1.37
17.66
4.4
4.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
761
5087
1.44
17.57
1.4
1.4
titre
684.0
539.2
0.87
140
952
(3010375) cycloSPORINE [Mass/volume] in Blood
66
185
3.31
17.49
29.4
25.2
ug/l
130.0
131.6
0.04
57
161
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3654
30649
1.31
17.48
4.3
3.7
pmol/l
14.5
14.5
0.06
3343
27674
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
98
345
2.64
17.40
2.9
2.6
e6/l
602.0
550.9
0.44
84
269
(3000060) B lymphocytes [#/volume] in Blood
72
214
3.13
17.36
3.1
2.6
e6/l
327.3
261.7
0.57
52
124
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
99
351
2.63
17.33
3.1
2.3
%
9.4
11.5
1.24
74
230
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
625
4034
1.48
17.30
3.1
2.4
%
21.9
23.3
1.94
547
3515
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
38
71
4.95
17.28
3.9
4.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
732
4875
1.44
17.22
2.9
2.3
umol/l
13.7
14.1
0.62
691
4552
(1175426) CD3 cells/100 lymphocytes in Blood
99
354
2.60
17.05
3.1
2.3
%
68.1
72.7
1.33
99
347
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
520
3241
1.53
17.02
2.0
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1691
12896
1.30
16.69
6.1
4.9
g/l
37.0
36.8
0.70
1590
12011
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
816
5579
1.41
16.54
1.3
1.2
u/ml
14.3
9.8
0.36
267
2163
(3024980) IgG subclass 4 [Mass/volume] in Serum
146
630
2.16
16.52
1.5
1.7
g/l
0.7
0.8
0.19
103
511
(3012095) Magnesium [Moles/volume] in Serum or Plasma
700
4657
1.44
16.52
7.9
4.5
mmol/l
0.8
0.8
2.55
657
4375
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1086
7784
1.36
16.50
1.7
1.6
mmol/l
1.4
1.3
0.96
928
6767
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
582
3740
1.49
16.43
4.4
3.3
umol/l
6.2
6.9
0.57
495
3197
(3004789) Transferrin [Mass/volume] in Serum or Plasma
666
4397
1.45
16.36
2.9
2.3
g/l
2.5
2.5
1.04
616
4100
(3018095) Leukocytes [#/volume] in Urine
1662
12701
1.30
15.99
4.6
3.5
e6/l
86.8
84.7
0.03
1221
8389
(36304419) Bacteria [Presence] in Urine
1286
9493
1.33
15.94
4.0
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
521
3296
1.50
15.86
2.1
1.7
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
121
493
2.29
15.75
3.1
3.1
mu/l
22.3
26.1
0.62
112
457
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1127
8187
1.34
15.55
2.4
2.2
u/l
175.7
240.9
1.14
1072
7760
(3031040) Bacteria [#/volume] in Urine by Automated count
2998
24714
1.27
15.32
5.1
3.9
e6/l
2690.6
1428.4
0.53
38
319
(3000991) Gas panel - Venous blood
490
3100
1.50
14.89
12.0
8.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
237
1255
1.77
14.80
3.9
3.6
%
163.9
168.9
0.41
225
1200
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1872
14660
1.27
14.47
3.1
2.3
nmol/l
72.0
71.5
0.38
1741
13553
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
165
789
1.95
14.21
2.2
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
164
785
1.95
14.09
2.3
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
166
800
1.94
13.98
9.7
5.8
iu/ml
815.3
648.8
0.16
27
90
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4110
35377
1.30
13.95
5.0
4.3
mu/l
1.9
1.9
0.25
3870
33058
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
351
2123
1.56
13.12
1.9
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
81
301
2.50
12.99
2.6
2.7
e6/l
804.3
867.9
0.25
24
106
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
251
1404
1.68
12.91
7.1
4.0
%
94.3
93.8
0.14
240
1310
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
54
162
3.09
12.91
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
217
1170
1.74
12.77
1.7
1.8
g/l
0.2
0.2
0.36
206
1117
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
307
1817
1.59
12.61
4.4
3.0
ng/l
127.1
161.7
1.08
280
1607
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3046
25442
1.24
12.59
3.5
2.9
u/l
39.0
36.4
1.22
2878
24093
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
469
3046
1.46
12.46
3.5
3.0
g/l
0.2
0.2
0.41
447
2840
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4572
40095
1.34
12.42
10.4
8.2
u/l
26.8
25.9
1.61
4416
38671
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
237
1322
1.68
12.33
5.5
3.9
g/l
3.5
3.4
0.77
223
1264
(3048929) Epstein Barr virus Ab [Presence] in Serum
461
2991
1.46
12.31
1.6
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
92
372
2.30
12.28
3.3
2.6
%
32.2
44.2
—
9
43
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
824
5900
1.34
12.25
1.3
1.3
iu/ml
21.8
26.0
0.65
229
1647
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
219
1199
1.71
12.22
1.7
1.8
g/l
1.2
1.2
0.13
208
1147
(3009261) Glucose [Presence] in Urine by Test strip
2304
18725
1.23
12.16
4.0
3.2
estimate
0.0
0.0
1.32
493
3657
(3036489) Thrombin time
264
1521
1.63
12.12
4.3
3.1
s
21.3
21.6
0.34
234
1311
(3035350) Ketones [Presence] in Urine by Test strip
2288
18588
1.23
12.09
3.9
3.2
estimate
0.0
0.0
1.34
489
3626
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
28
55
4.71
12.08
1.5
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4055
35043
1.27
11.98
4.1
3.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
145
705
1.92
11.95
5.6
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4022
34731
1.27
11.92
17.1
12.9
%
13.4
13.3
0.52
3940
33936
(3015377) Calcium [Moles/volume] in Serum or Plasma
1338
10257
1.27
11.85
2.9
2.9
mmol/l
2.4
2.4
0.08
1218
9150
(3026493) Urate [Moles/volume] in Serum or Plasma
940
6891
1.31
11.80
3.6
2.5
umol/l
3948.3
4393.3
0.14
827
6107
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1195
9053
1.28
11.63
2.4
2.3
mg/l
2.7
2.7
0.47
1052
7757
(3021601) Nitrite [Presence] in Urine by Test strip
2282
18587
1.23
11.60
5.4
4.4
estimate
0.0
0.0
0.50
517
3768
(3020393) Adenovirus Ag [Presence] in Stool
45
130
3.20
11.48
2.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4680
41275
1.35
11.46
12.6
9.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
546
3705
1.40
11.36
2.7
2.0
nmol/l
364.1
380.2
1.09
519
3412
(3020682) Albumin/Creatinine [Ratio] in Urine
947
6983
1.30
11.34
4.8
4.1
mg/mmol
9.5
12.0
0.41
634
4665
(3052851) Hemolysis interference index of Serum or Plasma
179
948
1.76
11.25
3.1
2.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
111
502
2.06
11.25
1.5
1.2
titre
253.3
408.0
—
6
10
(3012516) Albumin [Mass/volume] in Urine
909
6673
1.31
11.25
3.9
3.4
mg/l
331.9
385.3
0.15
623
4441
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
144
725
1.85
10.71
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
144
726
1.85
10.67
1.6
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
567
3928
1.37
10.38
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
107
493
2.02
10.35
4.4
2.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
113
531
1.98
10.34
2.0
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
808
5901
1.31
10.32
4.1
3.0
ng/l
957.7
1098.0
0.65
664
4846
(3030905) Polymorphonuclear cells [#/volume] in Blood
144
736
1.82
10.23
4.0
3.4
e9/l
3.9
3.9
0.05
144
736
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
150
779
1.79
10.11
1.5
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
147
759
1.80
10.10
4.5
3.6
%
56.2
55.5
0.30
147
759
(3009508) Creatinine [Moles/volume] in Urine
1252
9679
1.25
10.05
4.1
3.3
mmol/l
7.9
8.4
2.99
1086
8459
(3051651) Icteric interference index of Serum or Plasma
60
222
2.50
9.80
4.0
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1492
11782
1.23
9.80
1.9
1.8
pmol/l
96.6
96.5
0.01
808
6350
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
115
559
1.91
9.57
2.4
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2382
19726
1.20
9.54
3.3
2.8
ug/l
77.5
80.5
0.33
2253
18516
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
104
489
1.98
9.54
2.3
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
116
567
1.90
9.50
2.0
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
743
5426
1.30
9.45
3.3
2.7
e6/l
3.9
3.5
0.40
429
2794
(3007930) Methemoglobin/Hemoglobin.total in Blood
171
941
1.69
9.44
5.5
6.0
%
0.9
0.9
0.31
161
878
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
172
948
1.69
9.44
5.6
5.9
%
1.7
1.7
0.27
162
883
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3370
28830
1.21
9.43
5.0
4.2
mmol/mol
38.2
37.7
2.29
3150
27042
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
88
391
2.09
9.42
2.0
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
768
5645
1.29
9.29
3.2
2.6
e6/l
1.4
1.1
0.70
460
3012
(3022217) INR in Platelet poor plasma by Coagulation assay
414
2773
1.41
9.28
14.0
18.1
inr
1.2
1.2
0.12
59
457
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
194
1109
1.63
9.27
2.0
1.5
—
—
—
0
0
(3013512) EKG study
999
7589
1.26
9.26
3.5
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
354
2313
1.44
9.12
3.9
3.1
e9/l
69.2
69.4
0.02
264
1657
(44790049)
96
452
1.97
8.80
2.2
1.7
—
—
—
0
0
(44790047)
96
452
1.97
8.80
2.2
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
478
3310
1.36
8.76
4.8
3.3
%
1.6
1.6
0.96
419
2986
(3037121) Protein [Mass/volume] in Urine
208
1227
1.58
8.75
5.6
4.2
g/l
0.4
0.4
0.04
132
614
(44806118)
96
453
1.97
8.75
2.2
1.7
—
—
—
0
0
(44790048)
96
453
1.97
8.75
2.2
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
45
153
2.72
8.73
2.4
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
232
1406
1.54
8.68
1.8
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1362
10768
1.22
8.66
3.7
2.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
328
2136
1.44
8.61
3.0
2.4
ml/min/173m2
74.1
77.2
0.46
120
796
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
367
2442
1.41
8.56
3.3
3.3
pmol/l
4.7
4.7
0.00
335
2213
(36660697) Celiac disease serology panel - Serum
592
4253
1.32
8.46
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
499
3498
1.35
8.44
4.7
3.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
182
1050
1.62
8.41
2.1
1.5
u/ml
136.4
106.3
0.60
36
180
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
188
1094
1.60
8.39
1.9
1.6
titre
231.1
201.1
—
9
35
(3027273) Bicarbonate [Moles/volume] in Venous blood
208
1240
1.57
8.38
5.9
3.4
mmol/l
24.9
24.9
0.06
197
1191
(3017732) Neutrophils [#/volume] in Blood
362
2413
1.41
8.36
2.3
2.4
e9/l
4.3
4.2
0.32
299
1967
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
455
3150
1.36
8.35
5.2
4.4
u/l
244.3
246.6
0.06
437
2999
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
221
1337
1.54
8.34
1.9
1.3
u/ml
244.3
206.2
1.11
121
737
(3008757) Leukocyte morphology finding [Identifier] in Blood
80
363
2.04
8.15
3.9
3.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
91
433
1.95
8.13
1.9
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
135
729
1.72
8.04
2.8
2.0
g/l
133.9
132.6
0.21
113
569
(3048689) Calprotectin [Mass/mass] in Stool
835
6311
1.26
7.99
2.7
2.7
ug/g
126.8
115.5
0.33
650
4970
(3021960) Folate [Moles/volume] in Serum or Plasma
869
6600
1.25
7.97
1.5
1.5
nmol/l
20.2
19.9
0.23
757
5822
(3014111) Lactate [Moles/volume] in Serum or Plasma
388
2640
1.38
7.94
9.7
8.4
mmol/l
1.4
1.4
0.08
368
2504
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
333
2208
1.41
7.93
1.2
1.1
u/ml
4.6
3.9
—
5
28
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
316
4005
0.71
7.93
1.5
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
73
328
2.06
7.66
2.1
1.7
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
11
13
7.80
7.66
1.4
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1072
8365
1.22
7.63
5.9
4.2
%
91.6
91.5
0.07
1042
8149
(3051611) Lipemic interference index of Serum or Plasma
72
324
2.06
7.53
3.9
3.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
94
465
1.88
7.51
1.6
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
65
282
2.14
7.48
6.2
2.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
282
1837
1.44
7.43
3.3
2.4
g/l
67.0
66.9
0.07
270
1702
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
83
396
1.94
7.39
2.1
1.6
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
28
80
3.23
7.37
3.4
3.8
%
3.3
4.4
0.20
12
27
(3025941) Bacteria identified in Stool by Culture
348
2358
1.38
7.32
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
113
599
1.75
7.23
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3752
32727
1.19
7.18
3.8
3.4
mmol/l
5.7
5.6
1.02
3476
30206
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
96
488
1.83
7.07
7.3
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
280
1839
1.42
7.07
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
149
857
1.62
7.04
1.7
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
37
128
2.67
7.01
3.7
4.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
76
360
1.96
6.94
1.9
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
214
1341
1.49
6.91
2.6
1.5
u/ml
15.3
13.1
0.17
18
56
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
284
1879
1.41
6.89
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1760
14485
1.18
6.88
4.0
3.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
5015
45146
1.36
6.78
20.2
15.2
fl
89.0
89.2
3.04
4950
44492
(3010813) Leukocytes [#/volume] in Blood
5018
45180
1.36
6.75
20.3
15.3
e9/l
7.0
6.8
4.64
4887
43707
(3027315) Oxygen [Partial pressure] in Blood
130
731
1.65
6.73
5.5
3.9
kpa
9.4
9.1
1.18
130
717
(3028433) Virus identified in Specimen by Culture
37
131
2.61
6.72
1.4
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
116
634
1.70
6.69
3.3
2.2
%
17.8
17.0
1.50
73
291
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
230
1472
1.46
6.69
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
82
404
1.88
6.68
2.4
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5018
45187
1.36
6.67
20.5
15.3
g/l
136.1
135.6
1.60
4952
44538
(3003327) Ova and parasites identified in Stool by Light microscopy
258
1688
1.43
6.67
1.8
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
89
451
1.83
6.64
3.8
3.1
%
1.0
1.4
0.72
72
357
(3026361) Erythrocytes [#/volume] in Blood
5015
45159
1.36
6.64
20.3
15.2
e12/l
4.6
4.6
3.47
4877
43692
(3035941) MCH [Entitic mass]
5014
45149
1.36
6.63
20.2
15.2
pg
29.8
29.8
2.15
4947
44494
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
126
706
1.66
6.62
1.2
1.3
u/ml
18.2
3.1
—
8
52
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
20
49
3.77
6.61
1.4
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
5009
45100
1.35
6.60
20.3
15.3
e9/l
261.8
260.1
1.08
4884
43733
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
44
171
2.38
6.60
1.1
1.1
%
93.2
92.3
0.10
23
82
(3044889) 12 lead EKG panel
2536
21523
1.16
6.60
3.2
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
778
5964
1.23
6.49
1.6
1.6
pmol/l
45950596.9
27506348.1
0.35
642
5068
(3012501) Base excess in Blood by calculation
129
732
1.64
6.46
5.5
4.0
mmol/l
1.8
2.2
1.18
80
427
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3746
32775
1.17
6.46
11.1
9.2
ml/min/173m2
96.4
95.0
2.77
3021
25551
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
123
690
1.66
6.45
1.5
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
129
733
1.64
6.43
5.5
4.0
kpa
5.0
5.0
0.15
129
719
(3047181) Lactate [Moles/volume] in Blood
143
836
1.59
6.36
5.6
6.5
mmol/l
1.2
1.2
0.41
128
734
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
218
2829
0.70
6.29
1.3
1.3
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
50
210
2.20
6.29
1.8
1.9
nmol/l
0.2
0.1
1.07
35
163
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
53
228
2.15
6.29
1.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
53
228
2.15
6.29
1.7
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
53
228
2.15
6.29
1.7
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
337
2340
1.35
6.11
5.0
3.3
mmol/l
1.2
1.2
0.13
291
2007
(40760892) CBC W Ordered Manual Differential panel - Blood
1147
9180
1.19
6.11
5.7
4.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
220
1422
1.44
6.10
1.2
1.2
u/ml
1.1
0.9
0.09
12
107
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
42
166
2.34
6.09
1.2
1.3
%
88.0
90.6
0.16
23
82
(3040151) Glucose [Moles/volume] in Capillary blood
74
364
1.88
6.09
2.0
6.6
mmol/l
7.0
7.0
0.04
58
287
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
977
7716
1.20
6.02
1.7
1.5
—
—
—
0
0
(4010399)
310
2133
1.36
5.97
1.6
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
53
3.48
5.94
4.1
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
213
1377
1.44
5.91
13.1
11.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
151
910
1.54
5.91
2.0
1.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
68
329
1.91
5.90
1.3
1.2
u/ml
38.7
30.1
0.07
51
235
(3004119) Hemoglobin [Mass/volume] in Venous blood
256
1712
1.40
5.88
6.0
4.7
g/l
130.2
131.2
0.29
244
1671
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
65
310
1.94
5.88
1.5
1.2
u/ml
0.4
0.8
0.40
26
95
(3020961) Endomysium IgA Ab [Titer] in Serum
390
2785
1.31
5.84
1.2
1.2
titre
21.1
234.1
—
10
100
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
159
972
1.52
5.84
2.0
1.7
e6/l
271.5
4823.2
0.62
129
768
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
150
906
1.54
5.82
1.2
1.3
u/ml
7.8
14.6
0.97
20
145
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
148
897
1.53
5.66
1.2
1.3
u/ml
3.6
6.8
0.49
12
94
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
158
972
1.51
5.64
1.9
1.7
e6/l
21.9
19.6
0.05
117
733
(3023323) Follitropin [Units/volume] in Serum or Plasma
352
2494
1.32
5.59
1.7
1.5
iu/l
13.3
17.6
3.53
296
2013
(3019309) Folate [Moles/volume] in Red Blood Cells
614
4662
1.24
5.58
1.7
1.6
nmol/l
1118.9
1158.7
0.47
474
3550
(3010421) pH of Blood
142
856
1.54
5.58
5.9
3.8
ph
7.4
7.4
0.08
130
718
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
44
185
2.20
5.56
3.3
2.8
%
34.5
44.3
2.09
18
59
(3029937) Albumin [Presence] in Urine by Test strip
1246
10116
1.17
5.55
4.2
3.4
estimate
0.0
0.0
1.91
498
3644
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
172
1081
1.48
5.55
1.9
1.6
mg/l
617.4
449.1
0.51
160
1021
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
244
1637
1.39
5.52
1.6
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
27
91
2.74
5.44
3.1
2.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
88
474
1.72
5.42
1.7
1.9
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
44
188
2.16
5.36
1.7
1.9
%
129.6
138.1
0.35
44
178
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
354
2527
1.31
5.34
2.4
2.3
au/ml
12.7
20.4
1.64
28
185
(3016750) Collection duration of Urine
35
136
2.38
5.31
3.1
2.2
min
500.8
508.5
0.22
29
104
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
431
3159
1.28
5.31
2.6
2.3
u/l
28.0
35.5
3.70
365
2695
(3009214) Lutropin [Units/volume] in Serum or Plasma
301
2105
1.33
5.25
1.8
1.6
u/l
7.4
8.1
0.67
248
1650
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1994
16822
1.15
5.23
4.3
3.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
214
1418
1.41
5.22
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
33
126
2.42
5.21
2.2
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
200
1311
1.42
5.19
2.4
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
401
2923
1.28
5.17
3.2
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4372
38950
1.18
5.14
15.2
11.4
%
40.1
40.1
0.10
3451
31556
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
447
3306
1.27
5.12
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1297
10632
1.16
5.05
2.7
2.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
327
2331
1.31
5.00
1.3
1.3
au/ml
27.6
42.7
—
10
84
(3025018) Bordetella pertussis Ab [Titer] in Serum
70
363
1.79
4.95
1.2
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
118
703
1.56
4.93
2.8
3.2
umol/l
34.7
35.1
0.07
107
617
(3000492) Spirometry study
471
3523
1.25
4.91
1.5
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
88
490
1.66
4.85
1.2
1.2
u/ml
4.6
8.4
0.43
48
208
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
23
77
2.76
4.72
6.2
3.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
70
369
1.76
4.70
1.7
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
211
1424
1.38
4.66
3.4
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
54
264
1.89
4.62
3.8
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1054
8559
1.17
4.60
3.6
3.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
21
68
2.85
4.58
1.3
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
174
1140
1.42
4.58
3.0
2.8
umol/l
6.8
6.8
0.01
128
892
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
43
195
2.04
4.55
1.4
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3776
33366
1.14
4.55
4.1
3.6
mmol/l
2.8
2.8
0.20
3522
31204
(3024891) Influenza virus A+B Ag [Presence] in Specimen
187
1242
1.40
4.55
1.3
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
151
966
1.45
4.52
1.9
1.6
mmol/l
3.8
3.6
1.35
142
897
(3040893) Potassium [Moles/volume] in Capillary blood
10
19
4.85
4.50
3.1
2.8
mmol/l
4.2
4.4
—
10
19
(3045414) Leukocytes [Presence] in Urine
217
1482
1.36
4.47
1.7
1.8
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
35
148
2.18
4.43
1.3
1.2
%
107.9
106.3
0.11
30
132
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
90
519
1.61
4.36
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
132
829
1.48
4.36
1.5
1.4
ug/g
300.2
310.6
0.21
76
419
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
73
399
1.69
4.35
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
136
860
1.47
4.34
2.3
2.0
ug/l
1.4
1.9
0.25
119
764
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
153
990
1.43
4.33
1.2
1.3
u/ml
13.9
36.4
—
8
57
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
390
2901
1.26
4.29
2.0
1.9
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
22
76
2.67
4.28
1.2
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
39
175
2.06
4.27
3.2
2.2
ml
683.2
594.2
0.88
31
120
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
28
3.95
4.26
1.7
1.4
ng/l
134.0
99.6
0.33
12
28
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
38
169
2.08
4.26
1.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
70
381
1.70
4.24
1.2
1.1
iu/ml
8.9
6.4
0.26
15
88
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
32
133
2.22
4.24
1.6
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
32
133
2.22
4.24
1.6
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
32
133
2.22
4.24
1.6
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
32
133
2.22
4.24
1.6
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3746
33141
1.13
4.23
3.9
3.4
mmol/l
4.5
4.6
4.09
3528
31217
(3027801) Oxygen [Partial pressure] in Arterial blood
378
2808
1.26
4.21
9.6
8.4
kpa
13.0
13.4
0.66
358
2694
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
378
2808
1.26
4.21
9.7
8.4
kpa
5.2
5.0
1.42
357
2693
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
550
4257
1.21
4.17
2.7
2.4
u/l
7442.3
6921.0
0.10
199
1566
(3017354) Segmented neutrophils/100 leukocytes in Blood
53
268
1.83
4.13
3.4
3.0
%
54.6
53.7
0.08
37
179
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
531
4101
1.21
4.12
2.0
1.9
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
69
379
1.68
4.06
1.6
1.5
pmol/l
308.6
394.8
0.80
50
303
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
144
935
1.43
4.03
1.1
1.1
au/ml
28.1
11.8
—
6
69
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
59
311
1.75
4.02
1.6
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
101
611
1.53
4.01
5.2
5.2
umol/l
422.8
379.0
1.56
90
539
(3007566) Smooth muscle Ab [Titer] in Serum
152
998
1.41
4.00
1.5
1.4
titre
68.7
73.3
0.15
15
99
(1761482) Bacteria [#/volume] in Urine by Culture
102
619
1.53
4.00
3.8
3.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
443
3370
1.23
3.99
1.4
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
22
79
2.57
3.99
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
59
312
1.75
3.98
1.6
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
113
703
1.49
3.94
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
194
1331
1.35
3.92
13.3
11.4
mmol/l
24.2
24.1
0.21
183
1273
(3011985) Renin [Units/volume] in Plasma
72
404
1.65
3.92
1.7
1.7
mu/l
81.4
90.3
0.10
62
362
(3039000) Anion gap in Blood
90
536
1.55
3.85
7.3
8.5
mmol/l
11.1
11.5
0.75
80
482
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3702
32803
1.13
3.83
3.8
3.3
mmol/l
1.4
1.5
13.30
3468
30763
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
117
738
1.47
3.83
2.6
2.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
90
537
1.55
3.82
7.3
8.4
mmol/l
106.0
105.7
0.25
80
483
(3023511) Choriogonadotropin [Units/volume] in Urine
326
2410
1.26
3.81
1.5
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
377
2836
1.24
3.79
1.6
1.6
mu/l
324.5
337.7
0.31
328
2554
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
26
104
2.31
3.78
1.7
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
26
104
2.31
3.78
1.7
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
29
122
2.19
3.76
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
159
2.03
3.75
2.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
849
6890
1.16
3.70
1.7
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
199
1385
1.33
3.69
2.9
2.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
60
327
1.70
3.67
1.1
1.2
—
57.0
—
0
5
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
43
212
1.87
3.66
1.4
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
371
2799
1.24
3.64
9.8
8.4
mmol/l
1.2
0.8
1.02
281
2115
(3019225) pH of Specimen
347
2600
1.24
3.62
4.5
3.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
45
228
1.82
3.53
2.8
2.7
umol/l
60.2
55.5
0.37
37
199
(44813793)
72
417
1.60
3.50
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
167
1143
1.36
3.47
2.3
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3557
31520
1.12
3.46
3.5
3.1
mmol/l
1.3
1.2
4.37
3334
29540
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
31
140
2.04
3.40
1.3
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
22
86
2.36
3.39
3.3
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
68
394
1.60
3.32
1.8
1.6
titre
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
111
2.16
3.29
1.8
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
81
491
1.53
3.26
2.9
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
43
221
1.80
3.25
1.1
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
331
2500
1.23
3.24
10.4
8.9
%
95.9
96.0
0.05
314
2417
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
121
795
1.41
3.24
1.2
1.2
u/ml
79.7
36.0
—
5
61
(3013139) Helicobacter pylori Ag [Presence] in Stool
309
2317
1.24
3.24
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
36
175
1.90
3.23
1.9
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
31
143
2.00
3.23
1.3
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
454
3541
1.20
3.21
1.3
1.2
iu/ml
111.5
137.1
0.79
166
1281
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
30
137
2.02
3.21
2.6
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
181
1271
1.32
3.20
2.0
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
199
1419
1.30
3.16
1.1
1.1
u/ml
20.0
4.4
0.69
18
187
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
72
2.43
3.14
2.2
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
34
164
1.91
3.13
7.4
5.5
mg/l
101.7
2295.1
0.78
29
125
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
63
364
1.60
3.13
2.1
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
983
8150
1.13
3.13
2.6
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
297
2227
1.24
3.12
3.3
2.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
107
693
1.43
3.12
2.3
2.4
nmol/l
0.9
0.7
1.98
93
599
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
76
460
1.53
3.10
2.7
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
26
114
2.10
3.10
1.1
1.1
%
57.3
71.4
—
6
27
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
50
273
1.69
3.09
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
191
1361
1.30
3.06
1.5
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
434
3388
1.19
3.05
8.1
7.4
mmol/l
104.9
104.8
0.17
428
3320
(3014051) Protein [Presence] in Urine by Test strip
118
781
1.40
3.05
2.0
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
42
219
1.77
3.05
2.3
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
109
2.12
3.03
2.2
3.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
204
1471
1.29
2.99
1.2
1.1
u/ml
3.0
3.5
0.15
70
439
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
67
398
1.56
2.98
1.2
1.7
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
26
116
2.07
2.97
1.1
1.1
%
68.8
82.6
—
6
29
(3033086) Enterovirus NOS Ab [Titer] in Serum
8
15
4.91
2.97
1.1
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
25
110
2.10
2.96
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
160
1118
1.33
2.96
1.2
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
104
678
1.42
2.94
2.6
2.2
g/l
1.1
0.8
0.16
95
607
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
30
142
1.95
2.93
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
159
1112
1.33
2.92
1.2
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
195
0.33
2.92
2.0
2.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
195
0.33
2.92
4.0
5.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
210
1526
1.28
2.91
1.2
1.1
u/ml
6.4
7.3
0.34
135
948
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
11
32
3.17
2.90
3.4
2.7
mg/l
3.8
1.5
—
6
25
(3024471) HLA-A [Type]
30
143
1.94
2.88
1.0
1.0
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
32
156
1.89
2.88
2.8
2.4
mmol/l
1.8
1.7
0.11
26
116
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
47
258
1.68
2.87
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
760
6233
1.14
2.86
1.8
1.7
%
1.4
1.4
0.10
674
5642
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
416
3257
1.19
2.85
3.7
3.5
%
31.5
32.4
0.93
322
2317
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
48
266
1.67
2.84
1.3
1.2
u/l
155.6
77.5
0.40
36
197
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
30
144
1.92
2.83
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
64
382
1.55
2.81
1.3
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29
138
1.94
2.81
2.7
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
200
1452
1.28
2.80
1.2
1.1
u/ml
1.6
1.4
0.11
117
771
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
47
260
1.67
2.80
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
17
65
2.41
2.78
2.4
2.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
19
77
2.28
2.75
1.1
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
149
1044
1.32
2.73
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
160
1133
1.31
2.72
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
157
0.29
2.69
1.4
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
184
1330
1.28
2.68
1.8
1.9
u/l
38.1
39.5
0.44
170
1225
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
33
167
1.82
2.67
1.4
1.2
g/l
0.3
0.3
0.22
24
132
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
97
637
1.41
2.67
2.1
1.7
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
42
229
1.69
2.66
1.4
1.5
u/ml
0.3
8.4
2.09
11
62
(21494814) CD8 cells/100 lymphocytes in Specimen
26
122
1.97
2.63
3.0
2.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
41
223
1.70
2.62
1.1
1.0
u/ml
28.0
10.4
—
8
46
(3024932) HLA-DR beta [Type]
29
142
1.88
2.60
1.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
225
1675
1.25
2.58
1.3
1.1
u/ml
2.5
2.5
0.01
132
850
(3008116) Ketones [Moles/volume] in Urine by Test strip
17
68
2.31
2.54
2.0
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
23
3.61
2.54
1.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
148
1048
1.31
2.54
1.2
1.1
u/ml
10.7
8.7
0.25
84
521
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
140
984
1.32
2.53
2.1
1.9
iu/l
4.6
4.3
0.17
55
380
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
11
35
2.90
2.53
3.2
2.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
51
297
1.59
2.52
2.1
2.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
36
191
1.74
2.52
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
36
191
1.74
2.52
1.0
1.0
mmol/l
-0.5
-2.0
—
7
48
(3032773) Endomysium IgG Ab [Titer] in Serum
81
523
1.43
2.47
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
19
81
2.16
2.47
1.8
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
48
277
1.60
2.47
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
356
2792
1.19
2.43
2.4
2.1
nmol/l
10.0
11.2
1.84
308
2481
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
181
1324
1.27
2.43
5.4
4.6
%
0.7
0.7
2.12
172
1288
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
68
426
1.48
2.43
1.3
1.3
nmol/l
13.2
0.5
0.49
63
409
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
115
792
1.34
2.41
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
139
1648
0.77
2.40
1.3
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
18
76
2.18
2.40
2.9
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
105
714
1.36
2.39
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
167
1.77
2.38
1.6
1.6
u/l
7.9
6.4
0.19
21
93
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
786
1.34
2.37
2.8
2.1
g/l
7.2
7.4
0.63
95
609
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
786
1.34
2.37
2.8
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
786
1.34
2.37
2.8
2.1
g/l
3.5
3.8
1.56
89
577
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
20
3.69
2.36
2.1
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1478
12718
1.10
2.34
2.0
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
57
348
1.51
2.32
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
73
469
1.44
2.31
2.1
2.2
mmol/l
77.0
72.8
0.29
55
394
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
28
142
1.82
2.29
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
448
4703
0.87
2.25
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
23
110
1.93
2.24
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
23
110
1.93
2.24
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
935
7884
1.11
2.22
2.2
2.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
35
192
1.68
2.21
2.9
2.5
u/ml
645.7
1239.5
1.58
35
192
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
108
748
1.34
2.21
2.9
2.1
g/l
3.1
3.1
0.25
91
596
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
92
622
1.37
2.20
2.8
2.0
g/l
39.4
38.2
1.31
86
547
(4306422)
93
630
1.37
2.19
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
62
391
1.46
2.18
1.7
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
107
742
1.33
2.17
13.0
5.7
u/ml
0.3
0.3
0.13
71
419
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
89
600
1.37
2.17
1.1
1.1
%
118.3
115.6
0.37
82
535
(3047007) Chlamydophila sp Ab [Presence] in Serum
114
799
1.32
2.16
1.2
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
46
273
1.56
2.14
1.3
1.2
u/ml
16.0
9.2
0.41
35
205
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
101
696
1.34
2.14
1.2
1.1
iu/ml
50.4
729.0
0.62
25
215
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
62
393
1.46
2.13
1.7
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
64
409
1.45
2.11
5.0
3.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
57
356
1.48
2.11
1.2
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
6
13
4.25
2.11
4.3
3.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
62
394
1.45
2.11
1.7
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
62
394
1.45
2.11
1.7
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
21
100
1.94
2.09
2.1
2.7
umol/l
26.5
29.0
0.47
12
75
(4198724)
74
487
1.40
2.09
1.4
2.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1022
8687
1.10
2.08
3.7
3.2
kg/l
1.0
1.0
0.47
173
1262
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
105
732
1.33
2.07
2.6
2.1
g/l
10.5
10.3
0.11
97
631
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
5
9
5.12
2.07
11.2
3.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
5
9
5.12
2.07
1.2
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
73
480
1.41
2.07
1.1
1.1
—
1.8
—
0
5
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
20
94
1.96
2.06
1.1
1.2
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
21
101
1.92
2.04
1.0
1.0
u/ml
0.7
3.5
1.32
13
70
(3035947) Staphylolysin Ab [Units/volume] in Serum
31
169
1.69
2.03
1.1
1.1
iu/ml
2.4
5.1
—
5
19
(3019060) Gas panel - Arterial blood
198
1500
1.22
2.00
4.9
5.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
91
626
1.34
1.98
1.3
1.3
u/ml
4.3
4.9
0.21
44
290
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
61
393
1.43
1.95
1.7
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
37
214
1.60
1.95
2.1
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
17
77
2.04
1.94
6.5
6.4
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
24
123
1.80
1.94
1.0
1.0
u/ml
0.3
0.1
0.22
15
80
(3049233) Organic acids panel - Urine
11
41
2.47
1.93
1.3
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
62
402
1.42
1.92
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
303
3230
0.86
1.91
3.0
2.7
ug/l
0.8
0.7
0.13
183
1959
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
14
59
2.19
1.91
1.9
1.2
ng/l
24.5
71.3
—
8
30
(3048879) Bone marrow aspiration report
13
53
2.26
1.90
1.5
2.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
159
1184
1.24
1.90
1.7
2.0
g/l
1.4
1.4
0.16
139
1039
(3021788) Differential panel - Synovial fluid
71
473
1.39
1.90
1.5
1.6
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
7
20
3.22
1.88
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
306
2429
1.17
1.87
3.7
3.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
63
412
1.41
1.87
1.9
1.6
promille
1.2
1.3
0.38
50
310
(3000093) Morphology [Interpretation] in Blood Narrative
51
321
1.47
1.85
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1336
11552
1.09
1.85
2.4
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
154
1147
1.24
1.85
2.0
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
470
3852
1.13
1.84
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
155
1157
1.24
1.83
1.2
1.1
u/ml
5.8
6.0
0.04
89
534
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
57
368
1.43
1.82
1.2
1.3
nmol/l
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
11
4.19
1.81
6.2
12.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
245
1917
1.18
1.79
2.0
2.3
ug/l
5.9
6.4
0.18
206
1686
(3037756) Immunofixation for Serum or Plasma
59
385
1.42
1.79
1.9
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
37
2.49
1.79
2.3
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
80
550
1.34
1.78
1.3
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
74
1.99
1.75
6.9
6.3
—
—
—
0
0
(3032641) Amino acids panel - Urine
8
27
2.73
1.75
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
307
3244
0.86
1.74
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
38
228
1.54
1.74
1.4
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
163
1817
0.82
1.73
1.5
1.5
mg/l
3.4
3.9
0.41
125
1185
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
41
251
1.51
1.72
1.3
1.3
nmol/l
1.7
1.4
1.01
35
230
(3024928) Oxygen saturation in Venous blood
98
698
1.30
1.72
6.1
6.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
49
312
1.45
1.70
1.5
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
17
3.25
1.69
1.7
2.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
131
971
1.25
1.67
2.3
2.6
ug/l
221.4
463.1
2.10
116
886
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
29
165
1.62
1.66
1.8
1.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
109
1.78
1.66
1.7
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
109
1.78
1.66
1.7
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
109
1.78
1.66
1.7
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
40
247
1.49
1.63
2.3
2.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
76
527
1.33
1.62
1.2
1.2
u/ml
0.9
2.9
1.69
39
246
(1002224) Polysomnography panel
177
1360
1.20
1.61
1.1
1.1
—
—
—
0
0
(4268621)
65
441
1.36
1.60
2.3
2.4
—
—
—
0
0
(4027681)
54
355
1.40
1.60
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
29
167
1.60
1.60
1.2
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
46
294
1.44
1.59
2.7
4.6
mg/l
8.9
8.8
0.04
33
249
(3016135) IgD [Mass/volume] in Serum
5
13
3.54
1.58
1.2
1.3
mg/l
59.2
84.4
—
5
13
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
34
204
1.54
1.58
5.7
3.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
60
403
1.37
1.58
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
91
651
1.29
1.57
1.3
1.3
u/ml
3.0
4.2
0.38
30
226
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
178
1373
1.20
1.57
1.7
1.6
iu/ml
0.0
0.2
1.38
37
283
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
24
2.69
1.56
2.0
1.6
umol/24h
411.0
328.3
—
7
24
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
47
303
1.43
1.56
1.7
1.6
%
47.9
54.8
0.63
37
203
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
81
571
1.31
1.56
1.4
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
113
832
1.26
1.55
1.7
2.0
mg/l
9.1
10.4
1.30
106
783
(3052592) Norovirus Ag [Presence] in Stool
11
46
2.20
1.55
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
79
556
1.31
1.54
3.3
2.4
ug/min
160.5
99.0
0.41
60
352
(3016650) Hepatitis A virus Ab [Presence] in Serum
102
745
1.27
1.51
1.2
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
287
2314
1.15
1.49
10.3
9.0
g/l
125.3
123.0
1.07
272
2237
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1430
12497
1.07
1.49
2.6
2.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
43
276
1.44
1.47
1.2
1.1
ratio
1.0
1.1
1.29
15
107
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
92
666
1.28
1.47
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
21
114
1.70
1.45
1.8
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4032
36457
1.07
1.44
17.0
12.9
g/l
333.8
333.6
0.50
3996
36114
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
172
1.55
1.44
1.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
20
2.76
1.44
4.0
2.4
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
25
143
1.61
1.43
1.1
1.1
u/ml
0.2
1.3
0.84
19
75
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
150
1151
1.21
1.42
1.5
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
773
6607
1.09
1.42
2.1
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
17
88
1.78
1.38
1.2
1.4
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
20
109
1.69
1.38
3.1
2.0
nmol/l
5.4
2.8
0.32
20
102
(3028717) Thiamine [Mass/volume] in Blood
7
27
2.39
1.36
1.3
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
75
1.84
1.36
2.3
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
49
328
1.38
1.35
2.2
1.9
mg/l
26.3
26.3
0.00
16
93
(3034092) Cytoplasmic Ig cells/100 cells in Blood
13
62
1.93
1.34
13.4
4.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
35
221
1.46
1.32
1.3
1.3
e6/l
40082.7
59094.8
0.24
20
154
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
434
4398
0.90
1.32
4.0
3.7
%
22.4
21.1
0.82
177
1862
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
5
16
2.88
1.31
1.0
1.2
g/l
0.2
0.2
—
5
10
(3000475) Leukocytes [#/volume] in Synovial fluid
81
587
1.27
1.31
1.7
1.7
e6/l
14787.8
12347.6
0.14
58
435
(4094501)
83
604
1.27
1.30
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
61
426
1.32
1.30
1.1
1.2
mg/l
27.0
38.5
2.81
54
339
(3006653) Thiamine [Moles/volume] in Blood
27
162
1.54
1.30
1.3
1.4
nmol/l
150.1
134.8
0.71
27
162
(3019420) Tryptase [Mass/volume] in Serum or Plasma
41
269
1.41
1.28
1.4
1.5
ug/l
5.1
6.2
0.66
35
237
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
203
2151
0.86
1.27
1.5
1.5
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
24
141
1.57
1.26
1.1
1.1
u/ml
0.3
5.1
0.72
16
75
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
28
171
1.51
1.25
6.6
5.3
u/ml
345.5
131.7
—
8
32
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
119
908
1.21
1.23
1.1
1.1
u/ml
0.9
0.3
0.51
45
250
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
23
2.40
1.23
1.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
23
2.40
1.23
1.5
1.7
umol/l
40.2
46.2
—
6
23
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
32
202
1.46
1.23
1.1
1.1
nmol/l
11.2
3.6
—
7
39
(3015076) Soybean IgE Ab [Units/volume] in Serum
63
447
1.30
1.21
1.2
1.1
u/ml
0.6
1.3
0.42
15
103
(4035726)
280
2291
1.13
1.21
1.8
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
22
128
1.58
1.21
4.4
3.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
58
1.91
1.21
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1626
14360
1.06
1.20
2.2
2.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
40
265
1.39
1.20
2.3
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
410
3433
1.11
1.19
1.3
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
13
65
1.84
1.19
1.5
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
187
1490
1.16
1.19
6.5
7.0
mmol/l
25.2
24.1
3.22
169
1397
(3017704) Immunofixation for Urine
19
107
1.64
1.19
1.7
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
34
219
1.43
1.19
3.0
3.1
mg/l
112.4
38.5
1.25
24
171
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
258
1.39
1.18
1.3
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
35
227
1.42
1.18
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
47
321
1.35
1.18
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
77
564
1.26
1.17
1.3
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
21
122
1.59
1.17
1.1
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
18
2.56
1.17
1.8
3.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
47
322
1.35
1.16
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
47
322
1.35
1.16
1.1
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
30
190
1.46
1.15
1.9
1.6
u/l
6.8
7.3
0.11
24
157
(3014148) Varicella zoster virus Ab [Titer] in Serum
107
815
1.21
1.15
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
47
323
1.34
1.14
1.1
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
14
73
1.77
1.14
1.4
1.5
nmol/l
15.4
15.5
—
7
17
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
80
1.73
1.14
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
47
324
1.34
1.12
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
38
253
1.39
1.12
3.2
3.6
umol/l
161.6
175.2
0.11
24
145
(3004451) EKG impression Narrative
18
102
1.63
1.11
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
47
325
1.33
1.10
1.1
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
21
292
0.66
1.10
1.2
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
54
1.88
1.07
1.9
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
73
539
1.25
1.06
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
83
622
1.23
1.06
2.8
2.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
24
149
1.48
1.03
2.2
2.2
ml
2007.5
2058.7
0.08
24
138
(40768806) Pleura Pathology biopsy report
12
187
0.59
1.02
1.3
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
15
83
1.67
1.02
1.1
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
14
76
1.70
1.01
1.0
1.1
u/ml
0.0
0.0
—
8
40
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
52
371
1.29
1.00
1.4
1.4
titre
192.5
272.4
0.32
12
85
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
39
267
1.35
1.00
2.2
3.8
au/ml
211.0
79.6
—
9
40
(3034860) Kappa light chains.free [Mass/volume] in Serum
75
561
1.23
0.99
5.3
3.1
mg/l
47.0
65.6
0.50
58
458
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
112
872
1.19
0.99
1.2
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
26
166
1.44
0.98
2.7
2.3
umol/l
133.0
96.6
—
6
26
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
38
260
1.35
0.98
1.0
1.1
u/l
1.0
1.0
0.69
21
112
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
64
471
1.25
0.98
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
56
1.81
0.98
1.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
18
106
1.56
0.98
1.1
1.1
u/ml
8.2
13.3
0.63
12
69
(40757373) Influenza virus identified in Isolate
12
63
1.75
0.97
2.3
1.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
12
63
1.75
0.97
1.1
1.1
umol/24h
0.4
0.7
—
6
39
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
75
563
1.23
0.96
5.3
3.1
mg/l
35.4
50.1
0.52
58
461
(3000012) Reticulocyte production index
24
152
1.46
0.95
1.4
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
29
191
1.40
0.94
1.3
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
102
794
1.19
0.92
1.0
1.1
u/ml
4.3
3.0
0.30
38
348
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
35
240
1.34
0.90
1.4
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
154
1.44
0.90
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
180
1467
1.13
0.89
1.6
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
56
411
1.26
0.89
1.4
2.1
mosm/kgh2o
287.5
286.4
0.20
42
320
(3035880) pH of Pleural fluid
5
96
0.48
0.89
1.6
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
65
1.70
0.89
1.2
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
27
2.05
0.88
1.8
3.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
29
194
1.38
0.87
1.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
40
1.84
0.86
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
492
4846
0.93
0.86
1.5
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
13
73
1.64
0.86
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1221
10806
1.05
0.84
1.8
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
38
268
1.31
0.83
1.3
1.1
miu/ml
1459.7
1450.5
0.02
38
268
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
72
549
1.21
0.83
5.4
3.1
ratio
2.3
1.7
—
9
46
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
16
96
1.54
0.82
1.2
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
38
269
1.30
0.81
1.5
1.6
—
—
—
0
0
(4146454)
31
213
1.34
0.81
2.6
2.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
32
221
1.33
0.81
1.2
1.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
60
1.69
0.80
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
185
0.65
0.80
1.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
97
1.52
0.79
1.1
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
22
0.00
0.79
0.0
1.3
—
12.6
—
0
22
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
47
344
1.26
0.79
1.1
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
563
4881
1.07
0.79
2.3
2.7
mmol/l
2.4
2.4
0.63
485
4248
(3003740) Influenza virus B Ag [Presence] in Specimen
116
928
1.15
0.78
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
198
2020
0.90
0.77
3.2
4.1
ug/l
13.3
36.9
0.68
140
1564
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
50
370
1.25
0.77
1.3
1.3
u/l
44.6
36.7
0.11
44
324
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
40
288
1.28
0.77
1.7
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
31
1.78
0.77
1.3
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
11
61
1.66
0.76
1.1
1.2
g/l
42.0
39.6
—
5
39
(3017509) Phencyclidine [Presence] in Urine
16
98
1.50
0.76
1.1
2.3
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
26
0.00
0.76
0.0
1.0
—
0.1
—
0
15
(3002523) Influenza virus A Ag [Presence] in Specimen
116
931
1.15
0.75
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
184
1.35
0.75
1.3
1.3
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
9
49
1.69
0.75
1.3
1.8
pmol/l
17.8
20.9
—
9
44
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
68
745
0.84
0.73
1.6
1.6
mmol/l
7.2
7.3
0.15
37
449
(3041806) Other cells [#/volume] in Blood by Manual count
58
645
0.83
0.73
1.5
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
11
62
1.63
0.73
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
236
1984
1.10
0.72
2.3
2.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
52
1.59
0.71
1.3
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
289
2455
1.09
0.71
1.4
1.3
miu/ml
209.7
228.1
0.39
143
1191
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
24
1.92
0.70
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
31
219
1.30
0.70
1.1
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
38
1.70
0.69
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
78
1.54
0.69
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
33
236
1.29
0.68
3.0
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
880
7772
1.05
0.67
1.5
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
94
1.47
0.66
1.1
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
20
133
1.39
0.66
2.4
1.8
mmol/l
9.0
9.9
0.55
15
110
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
29
205
1.30
0.66
2.3
1.6
nmol/l
3.8
3.3
0.08
24
163
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
13
79
1.52
0.65
6.0
6.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
22
149
1.36
0.65
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
102
1.45
0.65
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
119
1231
0.89
0.63
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
141
1166
1.12
0.62
1.3
1.3
ug/l
4.0
4.6
0.72
132
1112
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
19
127
1.38
0.62
1.1
1.1
u/ml
0.1
0.7
1.20
11
76
(1761868) Lipid panel - Serum or Plasma
1361
12895
0.96
0.61
2.5
2.2
—
—
—
0
0
(4034850)
118
966
1.13
0.61
9.1
7.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
30
216
1.28
0.61
1.0
1.1
iu/ml
262.6
198.8
0.60
30
216
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
10
58
1.59
0.61
2.0
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
241
1.26
0.60
1.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
34
250
1.25
0.59
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
48
1.53
0.59
1.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
15
97
1.42
0.58
2.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
12
74
1.49
0.58
1.6
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
34
251
1.25
0.58
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
181
0.71
0.58
1.4
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
74
784
0.87
0.57
3.1
3.5
u/ml
1873.1
1729.7
0.02
64
668
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
249
2465
0.93
0.56
1.4
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
20
138
1.34
0.55
1.8
1.9
ug/min
54.1
166.8
—
7
32
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
244
2414
0.93
0.55
1.7
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
35
394
0.82
0.54
1.6
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
236
2334
0.93
0.53
1.9
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
135
0.68
0.52
2.1
1.8
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
35
263
1.23
0.52
1.1
1.0
u/ml
9.0
6.4
—
6
22
(3020891) Body temperature
121
1005
1.11
0.52
5.1
4.5
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
10
61
1.51
0.51
5.0
4.1
—
—
—
0
0
(4281824)
21
247
0.78
0.49
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
100
0.64
0.48
1.3
2.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
27
199
1.25
0.48
2.1
1.9
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
43
1.50
0.47
1.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
228
2244
0.93
0.47
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
94
777
1.12
0.46
1.5
1.4
u/l
10.7
15.7
2.10
86
676
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
79
0.58
0.45
2.0
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
79
0.58
0.45
2.0
2.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
229
2249
0.93
0.45
1.4
1.4
—
—
—
0
0
(4015189)
7
46
1.40
0.45
3.7
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
185
1.24
0.44
3.6
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
185
1.24
0.44
3.6
2.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
229
2246
0.94
0.44
1.4
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
37
402
0.85
0.43
3.8
3.9
u/ml
217.1
994.5
0.64
30
377
(3005033) Fetal Nuchal fold Thickness US
178
1760
0.93
0.43
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
184
1817
0.93
0.43
1.4
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
11
72
1.41
0.42
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
88
1.36
0.42
1.3
1.3
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
5
30
1.53
0.41
1.4
1.3
mg/l
1.4
1.3
—
5
25
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
16
0.00
0.40
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
31
1.48
0.40
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
229
2238
0.94
0.40
1.4
1.4
—
—
—
0
0
(4024509)
34
265
1.18
0.38
1.8
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
30
231
1.20
0.38
1.6
1.5
%
38.5
38.1
0.02
25
151
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
318
0.84
0.38
2.9
3.1
nmol/l
0.7
0.8
0.65
21
253
(3047352) Trisomy 18 risk [Likelihood] in Fetus
180
1767
0.94
0.37
1.4
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
34
1.35
0.37
1.0
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
27
207
1.20
0.36
1.1
1.1
%
89.1
91.1
0.11
22
162
(3019174) dRVVT (LA screen)
6
39
1.42
0.35
1.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
39
1.42
0.35
1.0
1.1
umol/24h
1.3
1.5
—
6
39
(3015183) Erythrocyte sedimentation rate
21
235
0.82
0.35
1.0
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
20
225
0.82
0.35
1.4
1.4
g/l
34.0
33.9
0.01
20
201
(4211845)
23
175
1.21
0.34
2.9
2.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
6
41
1.35
0.34
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
41
1.35
0.34
1.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
12
84
1.32
0.33
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
122
0.75
0.32
3.3
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
44
357
1.14
0.32
2.0
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
36
288
1.15
0.32
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
85
718
1.09
0.31
2.7
2.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
49
1.32
0.30
1.1
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
7
49
1.32
0.30
1.4
3.4
umol/l
26.7
44.0
—
7
39
(3045788) Cell count panel - Pleural fluid
15
171
0.81
0.30
1.4
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
7
50
1.29
0.30
1.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
19
144
1.22
0.30
1.5
1.5
u/l
16.7
13.0
1.00
19
139
(3019897) Erythrocyte distribution width [Ratio] by Automated count
60
609
0.91
0.29
4.2
2.0
%
13.3
13.0
2.40
60
603
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
22
170
1.19
0.29
1.5
1.6
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
52
1.24
0.29
1.1
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
52
1.24
0.29
1.1
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
78
1.30
0.28
2.4
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
29
231
1.16
0.28
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1480
13418
1.02
0.28
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
62
520
1.10
0.27
1.8
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
505
4516
1.03
0.27
1.8
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
495
4426
1.03
0.27
1.8
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
84
716
1.08
0.27
1.2
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
20
155
1.19
0.26
2.0
2.2
umol/l
15.3
16.0
0.11
20
155
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
592
5588
0.97
0.26
4.6
4.2
ug/l
1.7
2.3
2.14
532
5029
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
143
1245
1.06
0.26
2.0
1.6
nmol/l
38.2
40.0
0.33
143
1222
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
187
0.84
0.25
1.5
1.4
e6/l
19157.1
114323.6
—
7
107
(3028300) Cannabinoids [Presence] in Urine
505
4523
1.03
0.25
1.8
2.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
17
130
1.20
0.25
2.0
2.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
46
382
1.11
0.25
4.1
4.4
u/ml
491.7
125.9
—
9
121
(3021879) Hepatitis B virus core Ab [Presence] in Serum
462
4133
1.03
0.25
1.6
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
127
0.80
0.25
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
80
1.27
0.24
3.8
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
74
632
1.08
0.23
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
359
3408
0.97
0.23
4.9
5.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
65
647
0.92
0.23
1.7
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
35
1.32
0.23
1.6
2.1
u/field
0.8
0.9
—
5
35
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
35
1.32
0.23
1.2
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
66
656
0.93
0.23
1.2
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
36
1.28
0.23
15.0
10.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
17
184
0.85
0.22
1.2
1.3
mmol/l
6.9
6.4
0.33
17
169
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
37
1.24
0.22
5.8
8.5
mmol/l
5.6
6.5
—
5
37
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
37
1.24
0.22
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
81
1.25
0.22
1.1
1.2
—
—
—
0
0
(3036603) Volume of Urine
23
184
1.15
0.22
1.3
1.5
ml
1392.6
1983.6
—
5
29
(3023199) Leukocytes [#/volume] in Pleural fluid
20
213
0.86
0.22
1.4
1.4
e6/l
2078.2
2404.2
0.11
12
146
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
38
1.21
0.22
1.6
1.3
%
5.6
23.0
—
5
29
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
54
457
1.09
0.22
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
124
1.19
0.21
1.4
1.4
%
6.8
5.8
—
8
31
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
0
10
0.00
0.21
0.0
1.2
—
1.8
—
0
5
(3011288) Drugs identified in Urine by Screen method
353
3156
1.03
0.21
2.6
2.8
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
4.6
—
0.2
—
0
11
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.8
—
0
11
(40768795) Lymph node Pathology biopsy report
34
281
1.11
0.21
1.4
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
20
159
1.16
0.21
2.2
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
498
4479
1.03
0.20
1.8
2.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
99
1.21
0.20
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
82
1.24
0.20
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
44
1.26
0.20
1.0
1.0
—
—
—
0
0
(3019920) Amitriptyline [Moles/volume] in Serum or Plasma
0
13
0.00
0.20
0.0
1.7
—
520.3
—
0
8
(40758358) Immune stain study
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
133
0.83
0.20
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
172
0.86
0.20
1.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
46
1.20
0.19
4.2
2.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
38
318
1.10
0.19
1.1
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
12
91
1.21
0.19
1.0
1.0
g/l
166.6
163.0
0.26
12
91
(1001926) Buprenorphine [Presence] in Urine by Screen method
395
3546
1.03
0.19
1.9
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
461
4149
1.02
0.19
1.9
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
45
381
1.09
0.19
2.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
130
1250
0.96
0.18
1.2
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
116
1019
1.05
0.18
1.8
1.5
nmol/l
0.2
0.4
3.11
86
839
(3022670) pH of Venous cord blood
7
55
1.17
0.18
1.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
118
1.17
0.17
1.0
1.0
ng/l
916.8
706.8
—
10
72
(3028679) Herpes simplex virus Ab [Presence] in Serum
40
338
1.09
0.17
1.2
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
56
1.15
0.17
2.3
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
57
1.13
0.17
2.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
136
1.15
0.17
1.2
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
74
643
1.06
0.17
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
64
0.72
0.17
1.6
2.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
110
1.17
0.17
2.2
1.9
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
18
188
0.88
0.16
1.6
2.3
nmol/l
163.4
146.9
0.20
13
168
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
72
0.77
0.15
1.5
1.3
%
51.0
52.0
—
6
64
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
129
0.86
0.15
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
74
1.12
0.15
1.6
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
74
1.12
0.15
15.2
11.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
15
120
1.15
0.15
1.0
1.0
ng/l
340.1
275.4
—
10
76
(3051387) C reactive protein [Mass/volume] in Capillary blood
80
773
0.95
0.14
3.7
3.0
mg/l
22.4
25.8
0.50
51
481
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
83
0.78
0.14
3.6
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
48
414
1.07
0.14
1.3
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
38
376
0.93
0.14
1.6
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
121
1.14
0.13
2.5
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
94
901
0.96
0.13
1.6
1.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
100
0.83
0.13
1.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
143
1275
1.03
0.13
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
75
660
1.05
0.12
1.6
1.5
mmol/l
6.5
6.7
0.13
53
466
(3011648) Oxygen content in Venous blood
37
318
1.07
0.12
11.3
10.2
%
11.8
11.3
0.43
37
318
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
26
220
1.09
0.12
1.7
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
253
2376
0.98
0.11
1.6
1.6
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
47
410
1.06
0.10
1.3
1.4
nmol/l
28.4
32.0
0.36
40
373
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
41
1.12
0.10
2.2
1.5
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
5
41
1.12
0.10
1.6
1.2
ml/s/173m2
1.9
1.7
—
5
32
(3007463) Buprenorphine [Presence] in Urine
5
41
1.12
0.10
1.8
4.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
41
1.12
0.10
1.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
42
1.10
0.09
2.2
2.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
43
1.07
0.09
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
89
1.14
0.09
1.7
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
28
241
1.07
0.09
1.3
1.3
—
—
—
0
0
(44806420)
6
49
1.13
0.09
3.2
2.4
—
—
—
0
0
(4038314)
6
54
1.02
0.08
1.2
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
24
206
1.07
0.08
1.6
2.1
u/field
3.8
1.9
1.03
16
105
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
11
90
1.13
0.08
1.1
1.2
—
52.5
—
0
19
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
63
1.02
0.07
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
63
1.02
0.07
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
63
1.02
0.07
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
63
1.02
0.07
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
132
0.91
0.07
1.1
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
69
0.80
0.07
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
91
1.11
0.06
3.2
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
22
190
1.07
0.06
1.3
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
176
1646
0.98
0.06
1.9
2.7
u/ml
25.2
40.9
2.45
165
1594
(40765089) Chromosome analysis panel - Blood by G-banded
35
309
1.04
0.05
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
43
409
0.97
0.05
1.9
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
1031
9451
1.01
0.04
1.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
145
1353
0.99
0.04
1.7
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
196
1786
1.01
0.04
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
72
675
0.98
0.03
1.7
2.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
86
779
1.02
0.03
1.4
1.4
pmol/l
51.5
118.5
2.36
80
757
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
233
2128
1.01
0.03
2.0
2.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
51
480
0.98
0.03
1.4
1.4
mmol/l
11.3
11.4
—
10
72
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
99
0.93
0.02
1.7
1.4
ug/l
12.3
9.4
—
10
99
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
21
186
1.04
0.02
7.4
7.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
146
1334
1.01
0.01
1.9
1.9
—
—
—
0
0
(3019977) pH of Arterial blood
13
126
0.95
0.01
2.2
2.2
ph
7.5
7.4
—
6
34
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
126
0.95
0.01
1.1
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
10
98
0.94
0.01
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
123
1.05
0.01
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
36
337
0.98
0.00
1.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
124
0.96
0.00
1.1
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
11
99
1.02
0.00
1.2
1.3
nmol/l
71.5
139.3
—
6
71
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
18
166
1.00
0.00
1.1
1.1
ng/l
97.8
227.8
—
5
32
(3020650) Glucose [Presence] in Urine
13
116
1.03
0.00
1.5
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
129
1.00
0.00
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
83
759
1.01
0.00
1.8
1.6
titre
4288.0
1422.9
—
5
14
(4133840)
11
102
0.99
0.00
1.6
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
16
149
0.99
0.00
1.6
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
27
246
1.01
0.00
3.6
2.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
44
404
1.00
0.00
1.2
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
29
269
0.99
0.00
1.6
1.6
mmol/l
7.2
6.0
0.86
23
208
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
31
282
1.01
0.00
1.5
1.3
pmol/l
94.0
159.8
—
9
84
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
83.0
—
0
8
(3028714) Urate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
82
0.90
0.00
1.3
1.2
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
60.3
—
0
6
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
60
0.92
0.00
2.2
2.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
69
0.93
0.00
2.0
1.9
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
5
54
0.85
0.00
1.0
1.0
u/ml
0.5
0.2
—
5
44
(3036312) Salmon IgE Ab [Units/volume] in Serum
6
58
0.95
0.00
1.2
1.1
u/ml
0.4
2.0
—
6
42
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
132.3
—
0
7
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
82
0.90
0.00
1.1
1.1
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
1.1
—
0
7
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
81
0.91
0.00
1.1
1.1
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
62
0.89
0.00
2.2
2.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
5
55
0.84
0.00
1.8
1.3
mmol/l
4.2
3.5
—
5
48
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H8_OTIMEDNAS and mortality.

Females

Parameter HR [95% CI] p-value
H8_OTIMEDNAS 1.432 [1.19, 1.72] < 0.001
Birth year 0.995 [0.99, 1.0] 0.226

During the follow-up period (1.1.1998 — 31.12.2019), 1155 out of 59246 females with H8_OTIMEDNAS died.

Males

Parameter HR [95% CI] p-value
H8_OTIMEDNAS 1.551 [1.2, 2.01] < 0.001
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 1256 out of 71952 males with H8_OTIMEDNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_OTIMEDNAS.

N-year risk Females Males
1 0.138% 0.314%
5 0.738% 1.785%
10 2.034% 4.318%
15 3.894% 8.33%
20 7.097% 14.033%

Relationships between endpoints

Index endpoint: H8_OTIMEDNAS – Otitis media, unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data